furosemide has been researched along with Kidney Diseases in 278 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
Excerpt | Relevance | Reference |
---|---|---|
" Importantly, furosemide treatment did not further increase the expression of Kim-1 and NGAL in HK-2 cells upregulated by massive proteinuria." | 9.27 | Massive Proteinuria-Induced Injury of Tubular Epithelial Cells in Nephrotic Syndrome is Not Exacerbated by Furosemide. ( Jing, KP; Li, JJ; Liu, HF; Liu, WJ; Pan, Q; Tang, HX; Wang, S; Wu, HL; Xu, C; Ye, L; Zou, T, 2018) |
"20 patients with refractory nephrotic edema despite treatment with 80mg of furosemide daily and creatinine clearance > 60mL/min." | 9.24 | Acetazolamide and Hydrochlorothiazide Followed by Furosemide Versus Furosemide and Hydrochlorothiazide Followed by Furosemide for the Treatment of Adults With Nephrotic Edema: A Randomized Trial. ( Dormanesh, B; Fallahzadeh, MA; Fallahzadeh, MH; Fallahzadeh, MK; Roozbeh, J; Sagheb, MM, 2017) |
"5 or 15 mg/day) in combination with furosemide have been investigated in heart failure (HF) patients with normal kidney function but not in HF patients with advanced kidney dysfunction." | 9.20 | Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic study. ( Akashi, YJ; Kida, K; Kimura, K; Matsumoto, N; Miyake, F; Shibagaki, Y; Tominaga, N, 2015) |
"Furosemide is the diuretic of choice for the treatment of hypertension in chronic kidney disease but the adaptative changes in the distal nephron may decrease its efficacy." | 9.16 | A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease. ( Berland, Y; Dussol, B; Morange, S; Moussi-Frances, J; Mundler, O; Somma-Delpero, C, 2012) |
"A double-blind cross-over randomized clinical study with two different brands of furosemide was carried out in seven patients with edema of renal origin." | 9.06 | Comparative bioequivalence study of furosemide in patients with edema of renal origin. ( Garg, SK; Gupta, U; Mathur, VS; Sagar, S; Sharma, BK; Singh, A, 1987) |
"Studies were carried out in 15 patients with renal insufficiency and hypertension to compare the long-term effects of methyldopa and propranolol on renal hemodynamics." | 7.67 | Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency. ( Alterman, L; Bank, DE; Bank, N; Lowenstein, I; Zelen, R, 1984) |
"The purpose of this study was to define the effect of the angiotensin-converting enzyme inhibitor, enalapril maleate, on blood pressure, renal function, protein excretion, and potassium homeostasis in patients with hypertension associated with moderate to severe renal dysfunction." | 7.67 | Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction. ( Bauer, JH; Reams, GP, 1986) |
"We studied 10 patients with congestive heart failure to assess the dynamics of their response to 40 mg of furosemide." | 7.66 | Furosemide in patients with heart failure: shift in dose-response curves. ( Brater, DC; Chennavasin, P; Seiwell, R, 1980) |
"Obesity is an important risk factor for the development of chronic kidney disease." | 6.80 | Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial. ( Bar Sheshet Itach, S; Chagnac, A; Erman, A; Gafter, U; Herman-Edelstein, M; Ori, Y; Rozen-Zvi, B; Zingerman, B, 2015) |
"Furosemide treatment increased urine output by 7." | 6.68 | Impaired response to furosemide in hyperprostaglandin E syndrome: evidence for a tubular defect in the loop of Henle. ( Köckerling, A; Reinalter, SC; Seyberth, HW, 1996) |
"The combined prophylactic strategy of sodium bicarbonate plus N-acetylsyteine (NAC) seems to be effective in preventing contrast induced acute kidney injury (CI-AKI) in patients at low-to-medium risk." | 6.25 | Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design. ( Briguori, C; Condorelli, G; Ricciardelli, B; Visconti, G, 2011) |
" Importantly, furosemide treatment did not further increase the expression of Kim-1 and NGAL in HK-2 cells upregulated by massive proteinuria." | 5.27 | Massive Proteinuria-Induced Injury of Tubular Epithelial Cells in Nephrotic Syndrome is Not Exacerbated by Furosemide. ( Jing, KP; Li, JJ; Liu, HF; Liu, WJ; Pan, Q; Tang, HX; Wang, S; Wu, HL; Xu, C; Ye, L; Zou, T, 2018) |
"20 patients with refractory nephrotic edema despite treatment with 80mg of furosemide daily and creatinine clearance > 60mL/min." | 5.24 | Acetazolamide and Hydrochlorothiazide Followed by Furosemide Versus Furosemide and Hydrochlorothiazide Followed by Furosemide for the Treatment of Adults With Nephrotic Edema: A Randomized Trial. ( Dormanesh, B; Fallahzadeh, MA; Fallahzadeh, MH; Fallahzadeh, MK; Roozbeh, J; Sagheb, MM, 2017) |
"5 or 15 mg/day) in combination with furosemide have been investigated in heart failure (HF) patients with normal kidney function but not in HF patients with advanced kidney dysfunction." | 5.20 | Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic study. ( Akashi, YJ; Kida, K; Kimura, K; Matsumoto, N; Miyake, F; Shibagaki, Y; Tominaga, N, 2015) |
"Furosemide is the diuretic of choice for the treatment of hypertension in chronic kidney disease but the adaptative changes in the distal nephron may decrease its efficacy." | 5.16 | A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease. ( Berland, Y; Dussol, B; Morange, S; Moussi-Frances, J; Mundler, O; Somma-Delpero, C, 2012) |
"A double-blind cross-over randomized clinical study with two different brands of furosemide was carried out in seven patients with edema of renal origin." | 5.06 | Comparative bioequivalence study of furosemide in patients with edema of renal origin. ( Garg, SK; Gupta, U; Mathur, VS; Sagar, S; Sharma, BK; Singh, A, 1987) |
"To compare the efficacy of three commonly used diuretic regimens in the treatment of ascites, we randomized 90 patients to three treatment groups: Sequential Spironolactone (spironolactone followed by furosemide if necessary), Combination (spironolactone and furosemide in combination), and Furosemide (furosemide given alone)." | 5.05 | Diuresis in the ascitic patient: a randomized controlled trial of three regimens. ( Fogel, MR; Gregory, PB; Knauer, CM; Miller, RG; Neal, EA; Sawhney, VK, 1981) |
"Approximately one-third of patients with acute decompensated heart failure (ADHF) treated with an intravenous (iv) loop diuretic at a relatively high dose (>80 mg/day of furosemide, or an equivalent dose of another loop diuretic), exhibit worsening renal function (WRF) after a single course of iv infusions or iv bolus injections maintained for several days." | 3.83 | Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study. ( Baldi, C; De Vecchis, R; Di Biase, G, 2016) |
"Hypertension, renal dysfunction and furosemide administration at hospital admission are predictors of WRF among hospitalized patients." | 3.75 | Predictors of "worsening renal function" in patients hospitalized in internal medicine department. ( Al-Jabi, SW; Jayousi, HM; Sawalha, AF; Sweileh, WM; Zyoud, SH, 2009) |
" Kinetic parameters were determined in plasma and urine; further, in patients with liver cirrhosis, renal elimination kinetics of the diuretic were correlated with the concentration of direct plasma bilirubin, as a marker of cholestasis, at the beginning of a treatment with xipamide, 40 mg qd." | 3.73 | [Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients]. ( Knauf, H; Mutschler, E, 2005) |
" Eight dogs were over-diuresed with furosemide over a 2-day period, and 9 dogs were subjected to subacute hemorrhage over a similar period." | 3.68 | Renal response to atrial natriuretic peptide in nonedematous sodium-retaining dogs. ( Cernacek, P; Levy, M, 1992) |
"Studies were carried out in 15 patients with renal insufficiency and hypertension to compare the long-term effects of methyldopa and propranolol on renal hemodynamics." | 3.67 | Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency. ( Alterman, L; Bank, DE; Bank, N; Lowenstein, I; Zelen, R, 1984) |
" Moreover, urinary excretion of water, electrolytes, creatinine and urea nitrogen were estimated in order to check the pharmacodynamic effect of the drug." | 3.67 | Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function. ( Keil, E; Sperschneider, H; Stein, G; Traeger, A, 1984) |
"The purpose of this study was to define the effect of the angiotensin-converting enzyme inhibitor, enalapril maleate, on blood pressure, renal function, protein excretion, and potassium homeostasis in patients with hypertension associated with moderate to severe renal dysfunction." | 3.67 | Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction. ( Bauer, JH; Reams, GP, 1986) |
"Five patients with hepatorenal syndrome were treated with a LeVeen peritoneovenous shunt and furosemide." | 3.66 | Treatment of hepatorenal syndrome. ( Schwartz, ML; Vogel, SB, 1980) |
"We studied 10 patients with congestive heart failure to assess the dynamics of their response to 40 mg of furosemide." | 3.66 | Furosemide in patients with heart failure: shift in dose-response curves. ( Brater, DC; Chennavasin, P; Seiwell, R, 1980) |
"The furosemide arm was characterized by relatively high urine output after cisplatin administration (900 vs 550 mL/h), low frequency of unplanned additional hydration (14% vs 32%), and high incidence of hyponatremia (18% and 5%) compared with the mannitol arm." | 3.01 | Randomized study comparing mannitol with furosemide for the prevention of cisplatin-induced renal toxicity in non-small cell lung cancer: The OLCSG1406 trial. ( Hara, N; Hata, Y; Hotta, K; Ichihara, E; Itano, J; Kano, H; Kiura, K; Kubo, T; Maeda, Y; Makimoto, G; Minami, D; Nakanishi, M; Nakasuka, T; Ninomiya, K; Ninomiya, T; Nishii, K; Ohashi, K; Oze, I; Sato, A; Tabata, M; Watanabe, H, 2021) |
"Obesity is an important risk factor for the development of chronic kidney disease." | 2.80 | Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial. ( Bar Sheshet Itach, S; Chagnac, A; Erman, A; Gafter, U; Herman-Edelstein, M; Ori, Y; Rozen-Zvi, B; Zingerman, B, 2015) |
"We investigated the effects of low-dose furosemide, administered with adequate hydration on contrast-induced nephropathy (CIN)." | 2.78 | Low-dose furosemide administered with adequate hydration reduces contrast-induced nephropathy in patients undergoing coronary angiography. ( Chen, XF; Cui, W; Gu, GQ; Jia, WM; Liu, F; Lu, R; Yang, XH; Zhang, Y, 2013) |
"Furosemide treatment increased urine output by 7." | 2.68 | Impaired response to furosemide in hyperprostaglandin E syndrome: evidence for a tubular defect in the loop of Henle. ( Köckerling, A; Reinalter, SC; Seyberth, HW, 1996) |
"Piretanide was seen to have its most pronounced activity in the 1st h, while the effect of furosemide was more prolonged without abrupt peaks." | 2.65 | [Clinical comparative trial of piretanide and furosemide in patients with advanced renal insufficiency. Drug levels and diuretic potency of single oral doses]. ( Fink, R; Heuer, LJ; Machnik, H; Studt, J, 1983) |
" Important pharmacokinetic differences between adults and infants include a reduced clearance and prolonged half-life, that may cause accumulation of these agents to potentially toxic levels if dosing intervals are not adjusted." | 2.40 | The clinical pharmacology of loop diuretics in the pediatric patient. ( Christensen, ML; Eades, SK, 1998) |
"Cisplatin is a nephrotoxic drug; however, agents that may make cisplatin therapy more safe and rewarding will be available in the near future." | 2.38 | Newer insights into cisplatin nephrotoxicity. ( Anand, AJ; Bashey, B, 1993) |
"When introduced early in the course of diabetic nephropathy, ACEIs appear to produce greater reductions in urinary protein concentrations than do other antihypertensive agents, even when systemic blood pressure does not decrease." | 2.38 | Use of angiotensin-converting-enzyme inhibitors in the management of renal disease. ( Asher, JP; Murray, KM, 1991) |
"Lastly, in patients with congestive heart failure, with intravenous administration, resistance represents a pharmacodynamic phenomenon." | 2.37 | Resistance to loop diuretics. Why it happens and what to do about it. ( Brater, DC, 1985) |
"Drug treatment of renal hypertension is not essentially different from that of essential hypertension." | 2.35 | [Renal hypertension]. ( Reubi, F; Weidmann, P, 1976) |
" For predicting CIN, hs-CRP combined with procalcitonin showed an area under the receiver operating characteristic curve of 0." | 1.51 | Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention. ( Cui, W; Gu, G; Liu, D; Yuan, X; Zhou, Y, 2019) |
" However, choice of diuretic with pretreatment hydration had no significant impact on the severity of this adverse effect." | 1.46 | A retrospective evaluation of furosemide and mannitol for prevention of cisplatin-induced nephrotoxicity. ( Anderson, ML; Kha, C; Ludwig, M; Mach, CM; Meaders, KM; Nguyen, D; Shumway, J; Williams-Brown, MY, 2017) |
" Actually, a significant association with ARD was not present in any CHF patient with dilated left ventricle treated with high dosage of iv FUR, whereas a highly significant association with ARD was observed in HFNEF patients (OR: 72 95% CI: 6." | 1.37 | In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. ( Ariano, C; Cantatrione, S; Ciccarelli, A; Cioppa, C; De Vecchis, R; Giasi, A; Pucciarelli, A, 2011) |
" All these clinical drug-drug interactions (CDDIs) were with amphotericin B." | 1.34 | Drug-drug interactions with systemic antifungals in clinical practice. ( Abouelfath, A; Depont, F; Dupon, M; Dutronc, H; Galpérine, T; Giauque, E; Hébert, G; Moore, N; Ragnaud, JM; Valentino, R; Vargas, F, 2007) |
"Gitelman's syndrome is a recessively inherited renal tubular disorder characterized by low plasma potassium and magnesium levels, reduced calcium excretion, metabolic alkalosis, and increased plasma renin activity and plasma aldosterone concentration with normal blood pressure levels." | 1.33 | Diagnosis of a case of Gitelman's syndrome based on renal clearance studies and gene analysis of a novel mutation of the thiazide-sensitive Na-Cl cotransporter. ( Kageyama, K; Matsuda, E; Moriyama, T; Nigawara, T; Sakihara, S; Shoji, M; Suda, T; Terui, K; Tsutaya, S; Yasujima, M, 2005) |
"Our results suggest that dehydration or high plasma AVP results in an enhanced rBSC1 expression in Li nephropathy, and that rBSC1 expression is closely associated with the adverse effects of Li ions on collecting duct function." | 1.32 | Reverse pharmacological effect of loop diuretics and altered rBSC1 expression in rats with lithium nephropathy. ( Araki, T; Fujita, S; Imai, Y; Kazama, I; Kimura, T; Matsubara, M; Michimata, M; Mizukami, K; Muramatsu, Y; Sasaki, S; Suzuki, M, 2003) |
"Patients with renal colic are evaluated with clinical, laboratory, and imaging methods for stratification for emergency decompression, medical treatment, or discharge and follow up." | 1.31 | MAG3-F0 scintigraphy in decision making for emergency intervention in renal colic after helical CT positive for a urolith. ( Bird, VG; Block, NL; Braunstein, RH; Cohen, DJ; Georgiou, MF; Lerner, I; Leveillee, RJ; Lynne, CM; Sfakianakis, E; Sfakianakis, GN, 2000) |
"Colchicine treatment decreased the amount of sialic acid linked alpha(2-6) to galactose (NeuAc alpha 2-6Gal) and sialic acid linked alpha(2-3) to galactose (NeuAc alpha 2-3Gal) on THP and thereby decreased the aggregation rate with BJP without altering binding." | 1.29 | Biochemical interaction between Tamm-Horsfall glycoprotein and Ig light chains in the pathogenesis of cast nephropathy. ( Huang, ZQ; Sanders, PW, 1995) |
"A patient with persistent renal colic and a caliceal stone is presented." | 1.28 | Renal scintigraphy in the diagnosis and surgical management of a patient with caliceal colic: a case report. ( Arrington, ER; Eisenberg, B; Gibel, LJ; Mouchizadeh, J, 1990) |
" No dosage adjustment of felodipine seems to be necessary in patients with hypertension and renal impairment." | 1.28 | Acute and steady-state pharmacokinetics and antihypertensive effects of felodipine in patients with normal and impaired renal function. ( Aberg, J; Gelin, A; Karlberg, BE; Larsson, R; Regårdh, CG, 1990) |
" Survival of dosed and control rats of both sexes and male mice was similar; survival of high-dose female mice was lower than controls." | 1.28 | Toxicology and carcinogenicity studies of diuretics in F344 rats and B6C3F1 mice. 2. Furosemide. ( Bucher, JR; Davis, WE; Eustis, SL; Haseman, JK; Huff, J; Meierhenry, EF, 1990) |
"Pretreatment with choline chloride, PAH, furosemide and ethacrynic acid reduced the nephrotoxic action of CP in rat but did not prevent the accumulation of platinum in renal tissue which appeared to be a function of the dose injected to investigated animals." | 1.28 | Cisplatin: nephrotoxic action in vertebrates and its prevention. ( Bakhteeva, VT; Brovtsyn, VK; Myazina, EM; Reznik, LV, 1989) |
" The concentration of drug in serum and urine was measured during treatment, and pharmacokinetic parameters were evaluated on the second and last days; the parameters obtained on the 2 days did not differ significantly." | 1.27 | Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency. ( Berg, KJ; Nilsen, OG; Walstad, RA, 1983) |
" A statistically significant increase in ceftazidime elimination half-life and decreases in urinary recovery, total body clearance, and renal clearance in proportion to the decrease in renal function were observed (p less than 0." | 1.27 | The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy. ( Dahl, K; Hellum, KB; Thurmann-Nielsen, E; Walstad, RA, 1988) |
"Renal calculi were seen in four patients, sonographically demonstrated as echogenic foci in the dependent portion of the collecting system, usually accompanied by acoustic shadowing." | 1.27 | Ultrasound diagnosis of renal calcification in infants on chronic furosemide therapy. ( Adelman, RD; Goetzman, BW; McGahan, JP; Myracle, MR, 1986) |
" This article attempts to critically review these studies under seven different sections: furosemide pharmacokinetics in normal volunteers, furosemide pharmacokinetics in patients with decreased renal function, furosemide pharmacokinetics in patients with congestive heart failure, furosemide metabolism and assay methods, furosemide bioavailability, dose-response relationships, and the role of inhibitors and mediators on furosemide effects." | 1.26 | Pharmacokinetics/pharmacodynamics of furosemide in man: a review. ( Benet, LZ, 1979) |
" Although slight elevation of BUN and creatinine in plasma and hyaline casts in lumen of the distal tubules were observed in animals receiving 2,000 mg/kg of LMOX or CET when dosed with FUR, no histological changes were found in renal tissues." | 1.26 | [Comparative nephrotoxicity of latamoxef and other cephalosporins in rabbits. Combined administration with furosemide or tobramycin. (author's transl)]. ( Harada, Y; Okamoto, T; Teshima, K, 1981) |
" Severe leukopenia (WBC < 2000/cu mm) and thrombocytopenia (< 100,000/cu mm) occurred in 25% and 45% of evaluable courses, respectively and necessitated dosage reduction in all and delay of therapy in some patients." | 1.26 | Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms. ( Bachur, NR; Chang, P; Egorin, MJ; Hahn, D; Klein, M; Leroy, A; Markus, S; Ostrow, S; Wiernik, PH, 1980) |
"In 17 patients with chronic renal failure treated by haemodialysis and with arterial hypertension, PRA was likewise determined before and after injecting furosemide." | 1.26 | Response of peripheral plasma renin activity (PRA) to furosemide stimulation; reduction of the renal parenchyma as a limiting factor. ( Rotnáglová, Z; Stríbrná, J; Zabka, J, 1981) |
" The dosage of furosemide did not account for the increased frequency of ARs in patients with hepatic disease." | 1.26 | Furosemide-induced adverse reactions during hospitalization. ( Busto, U; Cassis, L; Naranjo, CA, 1978) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 148 (53.24) | 18.7374 |
1990's | 43 (15.47) | 18.2507 |
2000's | 51 (18.35) | 29.6817 |
2010's | 32 (11.51) | 24.3611 |
2020's | 4 (1.44) | 2.80 |
Authors | Studies |
---|---|
Avdeef, A | 1 |
Tam, KY | 1 |
Cechinel-Zanchett, CC | 1 |
Bolda Mariano, LN | 1 |
Boeing, T | 1 |
da Costa, JC | 1 |
Da Silva, LM | 1 |
Bastos, JK | 1 |
Cechinel-Filho, V | 1 |
de Souza, P | 1 |
Sridharan, K | 1 |
Al Jufairi, M | 1 |
Al Segai, O | 1 |
Al Ansari, E | 1 |
Hashem Ahmed, H | 1 |
Husain Shaban, G | 1 |
Malalla, Z | 1 |
Al Marzooq, R | 1 |
Al Madhoob, A | 1 |
Saeed Tabbara, K | 1 |
Zheng, H | 1 |
Wang, G | 1 |
Cao, Q | 1 |
Ren, W | 1 |
Xu, L | 1 |
Bu, S | 1 |
Murakami, E | 1 |
Akamatsu, H | 1 |
Shimokawa, T | 1 |
Wada, K | 1 |
Yamamoto, N | 1 |
Makimoto, G | 1 |
Hotta, K | 1 |
Oze, I | 1 |
Ninomiya, K | 1 |
Nakanishi, M | 1 |
Hara, N | 1 |
Kano, H | 1 |
Watanabe, H | 1 |
Hata, Y | 1 |
Nishii, K | 1 |
Nakasuka, T | 1 |
Itano, J | 1 |
Ninomiya, T | 1 |
Kubo, T | 1 |
Ohashi, K | 1 |
Ichihara, E | 1 |
Minami, D | 1 |
Sato, A | 1 |
Tabata, M | 1 |
Maeda, Y | 1 |
Kiura, K | 1 |
Inomata, T | 1 |
Ikeda, Y | 1 |
Kida, K | 2 |
Shibagaki, Y | 2 |
Sato, N | 1 |
Kumagai, Y | 1 |
Shinagawa, H | 1 |
Ako, J | 1 |
Izumi, T | 1 |
Wang, S | 2 |
Pan, Q | 1 |
Xu, C | 1 |
Li, JJ | 1 |
Tang, HX | 1 |
Zou, T | 1 |
Jing, KP | 1 |
Ye, L | 1 |
Wu, HL | 1 |
Liu, WJ | 1 |
Liu, HF | 1 |
Okuhara, Y | 1 |
Asakura, M | 1 |
Azuma, K | 1 |
Orihara, Y | 1 |
Nishimura, K | 1 |
Ando, T | 1 |
Kondo, H | 1 |
Naito, Y | 1 |
Kashiwase, K | 1 |
Hirotani, S | 1 |
Ishihara, M | 1 |
Masuyama, T | 1 |
De Lavallaz, L | 1 |
Musso, CG | 1 |
Gu, G | 1 |
Yuan, X | 1 |
Zhou, Y | 1 |
Liu, D | 1 |
Cui, W | 2 |
Gu, GQ | 1 |
Lu, R | 1 |
Liu, F | 1 |
Zhang, Y | 1 |
Yang, XH | 1 |
Chen, XF | 1 |
Jia, WM | 1 |
Ege, MR | 1 |
Yilmaz, MB | 1 |
Tominaga, N | 1 |
Matsumoto, N | 1 |
Akashi, YJ | 1 |
Miyake, F | 1 |
Kimura, K | 1 |
Zacchia, M | 1 |
Capasso, G | 1 |
De Vecchis, R | 2 |
Baldi, C | 1 |
Di Biase, G | 1 |
Labriola, L | 1 |
Olinger, E | 1 |
Belge, H | 1 |
Pirson, Y | 1 |
Dahan, K | 1 |
Devuyst, O | 1 |
Duan, N | 1 |
Zhao, J | 1 |
Li, Z | 1 |
Dong, P | 1 |
Zhao, Y | 1 |
Wang, L | 1 |
Wang, H | 1 |
ter Maaten, JM | 1 |
Valente, MA | 1 |
Metra, M | 1 |
Bruno, N | 1 |
O'Connor, CM | 1 |
Ponikowski, P | 1 |
Teerlink, JR | 1 |
Cotter, G | 1 |
Davison, B | 1 |
Cleland, JG | 2 |
Givertz, MM | 1 |
Bloomfield, DM | 1 |
Dittrich, HC | 1 |
van Veldhuisen, DJ | 1 |
Hillege, HL | 1 |
Damman, K | 2 |
Voors, AA | 1 |
Zingerman, B | 1 |
Herman-Edelstein, M | 1 |
Erman, A | 1 |
Bar Sheshet Itach, S | 1 |
Ori, Y | 1 |
Rozen-Zvi, B | 1 |
Gafter, U | 1 |
Chagnac, A | 1 |
Kjekshus, J | 1 |
Wikstrand, J | 1 |
Komajda, M | 1 |
Wedel, H | 1 |
Waagstein, F | 1 |
McMurray, JJ | 1 |
Li, J | 1 |
Guo, Z | 1 |
Zhao, X | 1 |
Ma, Y | 1 |
Han, P | 1 |
Feng, S | 1 |
Fallahzadeh, MA | 1 |
Dormanesh, B | 1 |
Fallahzadeh, MK | 1 |
Roozbeh, J | 1 |
Fallahzadeh, MH | 1 |
Sagheb, MM | 1 |
Mach, CM | 1 |
Kha, C | 1 |
Nguyen, D | 1 |
Shumway, J | 1 |
Meaders, KM | 1 |
Ludwig, M | 1 |
Williams-Brown, MY | 1 |
Anderson, ML | 1 |
Tuma, J | 1 |
Schwarzenbach, HR | 1 |
Nováková, B | 1 |
Jungius, KP | 1 |
Kuchta, M | 1 |
Gottlieb, SS | 1 |
Vivier, PH | 1 |
Blondiaux, E | 1 |
Dolores, M | 1 |
Marouteau-Pasquier, N | 1 |
Brasseur, M | 1 |
Petitjean, C | 1 |
Dacher, JN | 1 |
Andriessen, P | 1 |
Struis, NC | 1 |
Niemarkt, H | 1 |
Oetomo, SB | 1 |
Tanke, RB | 1 |
Van Overmeire, B | 1 |
Sfakianakis, GN | 3 |
Sfakianaki, E | 1 |
Georgiou, M | 1 |
Serafini, A | 1 |
Ezuddin, S | 1 |
Kuker, R | 1 |
Zilleruelo, G | 1 |
Strauss, J | 1 |
Abitbol, C | 1 |
Chandar, J | 1 |
Seeherunvong, W | 1 |
Bourgoignie, J | 1 |
Roth, D | 1 |
Leveillee, R | 1 |
Bird, VG | 3 |
Block, N | 1 |
Gosalbez, R | 1 |
Labbie, A | 1 |
Guerra, JJ | 1 |
Yrizarry, J | 1 |
Sweileh, WM | 1 |
Sawalha, AF | 1 |
Jayousi, HM | 1 |
Zyoud, SH | 1 |
Al-Jabi, SW | 1 |
Kopac, M | 1 |
Casale, P | 1 |
Kaplan, BS | 1 |
Mitrovic, V | 1 |
Seferovic, P | 1 |
Dodic, S | 1 |
Krotin, M | 1 |
Neskovic, A | 1 |
Dickstein, K | 1 |
de Voogd, H | 1 |
Böcker, C | 1 |
Ziegler, D | 1 |
Godes, M | 1 |
Nakov, R | 1 |
Essers, H | 1 |
Verboom, C | 1 |
Hocher, B | 1 |
Kunt, AT | 1 |
Akgün, S | 1 |
Atalan, N | 1 |
Bitir, N | 1 |
Arsan, S | 1 |
Bagshaw, SM | 1 |
Gibney, RT | 1 |
McAlister, FA | 1 |
Bellomo, R | 1 |
Sourbron, S | 1 |
Ciccarelli, A | 1 |
Ariano, C | 1 |
Cioppa, C | 1 |
Giasi, A | 1 |
Pucciarelli, A | 1 |
Cantatrione, S | 1 |
Briguori, C | 1 |
Visconti, G | 1 |
Ricciardelli, B | 1 |
Condorelli, G | 1 |
Takenaka, T | 1 |
Uchida, K | 1 |
Kojima, E | 1 |
Gen, S | 1 |
Nodaira, Y | 1 |
Hoshi, H | 1 |
Kato, N | 1 |
Takane, H | 1 |
Ohno, Y | 1 |
Suzuki, H | 1 |
Marenzi, G | 1 |
Ferrari, C | 1 |
Marana, I | 1 |
Assanelli, E | 1 |
De Metrio, M | 1 |
Teruzzi, G | 1 |
Veglia, F | 1 |
Fabbiocchi, F | 1 |
Montorsi, P | 1 |
Bartorelli, AL | 1 |
Dussol, B | 2 |
Moussi-Frances, J | 1 |
Morange, S | 2 |
Somma-Delpero, C | 1 |
Mundler, O | 1 |
Berland, Y | 2 |
Izzo, JL | 1 |
Yagci, C | 1 |
Ustuner, E | 1 |
Atman, ED | 1 |
Baltaci, S | 1 |
Uzun, C | 1 |
Akyar, S | 1 |
Akgun, V | 1 |
Battal, B | 1 |
Kocaoglu, M | 1 |
Ozcan, E | 1 |
Akay, S | 1 |
Ilgan, S | 1 |
Johnstone, LK | 1 |
Mayhew, IG | 1 |
Budau, M | 1 |
Onu, M | 1 |
Jinga, V | 1 |
Braticevici, B | 1 |
Pop, T | 1 |
Michimata, M | 1 |
Fujita, S | 1 |
Araki, T | 1 |
Mizukami, K | 1 |
Kazama, I | 1 |
Muramatsu, Y | 1 |
Suzuki, M | 1 |
Kimura, T | 1 |
Sasaki, S | 1 |
Imai, Y | 1 |
Matsubara, M | 1 |
Chen, HH | 1 |
Redfield, MM | 1 |
Nordstrom, LJ | 1 |
Cataliotti, A | 1 |
Burnett, JC | 1 |
Santoso, JT | 1 |
Lucci, JA | 1 |
Coleman, RL | 1 |
Schafer, I | 1 |
Hannigan, EV | 1 |
Donoso, G | 1 |
Ham, H | 1 |
Tondeur, M | 1 |
Piepsz, A | 1 |
Coffey, JP | 1 |
Mank, A | 1 |
Semin-Goossens, A | 1 |
Lelie, Jv | 1 |
Bakker, P | 1 |
Vos, R | 1 |
Jain, S | 1 |
Cosgriff, PS | 1 |
Turner, DT | 1 |
Aslam, M | 1 |
Morrish, O | 1 |
Caimmi, PP | 1 |
Pagani, L | 1 |
Micalizzi, E | 1 |
Fiume, C | 1 |
Guani, S | 1 |
Bernardi, M | 2 |
Parodi, F | 1 |
Cordero, G | 1 |
Fregonara, M | 1 |
Kapetanakis, E | 1 |
Panella, M | 1 |
Degasperis, C | 1 |
THOMS, RK | 1 |
SPRINGMAN, FR | 1 |
WILSON, HE | 1 |
HEIDLAND, A | 1 |
KLUETSCH, K | 1 |
SUZUKI, F | 1 |
BERMAN, LB | 1 |
EBRAHIMI, A | 1 |
KIESSLING, J | 1 |
BUCHBORN, E | 1 |
ANASTASAKIS, S | 1 |
Carcoana, OV | 1 |
Mathew, JP | 1 |
Davis, E | 1 |
Byrne, DW | 1 |
Hayslett, JP | 1 |
Hines, RL | 1 |
Garwood, S | 1 |
Moyano Calvo, JL | 1 |
Gómez Benítez, S | 1 |
Cambil Molina, T | 1 |
Castiñeiras Fernández, J | 1 |
Lepor, NE | 1 |
Chiang, SB | 1 |
Doyle, A | 1 |
Alavi, A | 1 |
Zhuang, H | 1 |
Heidenreich, S | 1 |
Biancofiore, G | 1 |
Della Rocca, G | 1 |
Bindi, L | 1 |
Romanelli, A | 1 |
Esposito, M | 1 |
Meacci, L | 1 |
Urbani, L | 1 |
Filipponi, F | 1 |
Mosca, F | 1 |
Rocca, GD | 1 |
Pompei, L | 1 |
Costa, MG | 1 |
Coccia, C | 1 |
Scudeller, L | 1 |
Marco, PD | 1 |
Monaco, S | 1 |
Pietropaoli, P | 1 |
Tokumoto, T | 1 |
Tanabe, K | 1 |
Toma, H | 1 |
Akiba, T | 1 |
Cheong, HI | 1 |
Lee, JW | 1 |
Zheng, SH | 1 |
Lee, JH | 1 |
Kang, JH | 1 |
Kang, HG | 1 |
Ha, IS | 1 |
Lee, SJ | 1 |
Choi, Y | 1 |
Knauf, H | 1 |
Mutschler, E | 1 |
Minutolo, R | 2 |
De Nicola, L | 2 |
Zamboli, P | 2 |
Chiodini, P | 1 |
Signoriello, G | 1 |
Toderico, C | 1 |
Arfè, G | 1 |
Boschi, G | 1 |
Brancati, C | 1 |
Iaccarino, P | 1 |
Conte, G | 2 |
Buyukdereli, G | 2 |
Guney, IB | 1 |
Seydaoglu, G | 1 |
Charles, J | 1 |
Miller, G | 1 |
Ng, A | 1 |
Kageyama, K | 1 |
Terui, K | 1 |
Shoji, M | 1 |
Tsutaya, S | 1 |
Matsuda, E | 1 |
Sakihara, S | 1 |
Nigawara, T | 1 |
Moriyama, T | 2 |
Yasujima, M | 1 |
Suda, T | 1 |
Loundoun, A | 1 |
Auquier, P | 1 |
Sanyal, R | 1 |
Deshmukh, A | 1 |
Singh Sheorain, V | 1 |
Taori, K | 1 |
Bertino, V | 1 |
Catapano, F | 1 |
Ergen, FB | 1 |
Hussain, HK | 1 |
Carlos, RC | 1 |
Johnson, TD | 1 |
Adusumilli, S | 1 |
Weadock, WJ | 1 |
Korobkin, M | 1 |
Francis, IR | 1 |
Chan, YH | 1 |
Wong, KM | 1 |
Kwok, PC | 1 |
Liu, AY | 1 |
Choi, KS | 1 |
Chau, KF | 1 |
Li, CS | 1 |
Montagnac, R | 1 |
Blaison, D | 1 |
Ciupea, A | 1 |
Für, A | 1 |
Pradel, J | 1 |
Schillinger, F | 1 |
Depont, F | 1 |
Vargas, F | 1 |
Dutronc, H | 1 |
Giauque, E | 1 |
Ragnaud, JM | 1 |
Galpérine, T | 1 |
Abouelfath, A | 1 |
Valentino, R | 1 |
Dupon, M | 1 |
Hébert, G | 1 |
Moore, N | 1 |
Abbasi, AH | 1 |
Ramadan, R | 1 |
Hoffman, A | 1 |
Abassi, Z | 1 |
Izdes, S | 1 |
Kesimci, E | 1 |
Kanbak, O | 1 |
Vorburger, C | 1 |
Cottier, P | 1 |
Bufalari, A | 1 |
Meloni, G | 1 |
Marmo, R | 1 |
Persico, M | 1 |
Costume, A | 1 |
Bronzino, P | 1 |
Del Vecchio, E | 1 |
Gentile, S | 1 |
Porcellini, M | 1 |
Shapiro, SB | 1 |
Girassi, S | 1 |
Ash, JM | 1 |
Gilday, DL | 1 |
Doerr, BI | 1 |
Glomot, R | 1 |
Kief, H | 1 |
Kramer, M | 1 |
Sakaguchi, T | 1 |
Scharf, SC | 1 |
Blaufox, MD | 1 |
Murphy, BF | 1 |
Whitworth, JA | 1 |
Kincaid-Smith, P | 1 |
Lowenstein, I | 1 |
Alterman, L | 1 |
Zelen, R | 1 |
Bank, DE | 1 |
Bank, N | 1 |
Tan, LB | 1 |
Alpert, RA | 1 |
Roizen, MF | 1 |
Hamilton, WK | 1 |
Stoney, RJ | 1 |
Ehrenfeld, WK | 1 |
Poler, SM | 1 |
Wylie, EJ | 1 |
Zabka, J | 1 |
Stríbrná, J | 1 |
Rotnáglová, Z | 1 |
Harada, Y | 1 |
Teshima, K | 1 |
Okamoto, T | 1 |
Traeger, A | 1 |
Stein, G | 1 |
Sperschneider, H | 1 |
Keil, E | 1 |
Sakakibara, Y | 1 |
Fukuda, I | 1 |
Koishizawa, T | 1 |
Jikuya, T | 1 |
Sakai, A | 1 |
Okamura, K | 1 |
Maeta, H | 1 |
Ijima, H | 1 |
Mitsui, T | 1 |
Hori, M | 1 |
Prandota, J | 3 |
Houin, G | 1 |
Banaszak, A | 1 |
Tillement, JP | 1 |
Heuer, LJ | 1 |
Machnik, H | 1 |
Studt, J | 1 |
Fink, R | 1 |
Uchino, K | 1 |
Isozaki, S | 1 |
Saitoh, Y | 1 |
Nakagawa, F | 1 |
Tamura, Z | 1 |
Tanaka, N | 1 |
Mihindukulasuriya, J | 1 |
Lee, HA | 1 |
Trollfors, B | 1 |
Suurkula, M | 1 |
Price, JD | 1 |
Norrby, R | 1 |
Greenwalt, TJ | 1 |
Konrads, A | 1 |
Hummerich, W | 1 |
Vlaho, M | 1 |
Meurer, KA | 1 |
Pytĕl, JA | 1 |
Hradec, E | 1 |
Zolotarev, II | 1 |
Kazimirov, VG | 1 |
Dvorácek, J | 1 |
Skrivanová, V | 1 |
Walstad, RA | 2 |
Nilsen, OG | 1 |
Berg, KJ | 1 |
Berthold, F | 1 |
von Hattingberg, HM | 1 |
Lampert, F | 1 |
Morgan, T | 1 |
Carney, S | 1 |
Myers, J | 1 |
Lewy, JE | 2 |
Wilkinson, R | 1 |
Sellars, L | 1 |
Pickering, M | 1 |
Robson, V | 1 |
Kerr, DN | 1 |
Fogel, MR | 1 |
Sawhney, VK | 1 |
Neal, EA | 1 |
Miller, RG | 1 |
Knauer, CM | 1 |
Gregory, PB | 1 |
Yeh, TF | 1 |
Wilks, A | 1 |
Singh, J | 1 |
Betkerur, M | 1 |
Lilien, L | 1 |
Pildes, RS | 1 |
Holzgreve, H | 2 |
Ostrow, S | 1 |
Egorin, MJ | 1 |
Hahn, D | 1 |
Markus, S | 1 |
Leroy, A | 1 |
Chang, P | 1 |
Klein, M | 1 |
Bachur, NR | 1 |
Wiernik, PH | 1 |
Walzl, HL | 1 |
Mirahmadi, MK | 1 |
Vaziri, ND | 1 |
Whiting, PH | 1 |
Petersen, J | 1 |
Simpson, JG | 1 |
O'Reilly, PH | 2 |
Lupton, EW | 1 |
Testa, HJ | 1 |
Shields, RA | 1 |
Carroll, RN | 1 |
Edwards, EC | 1 |
Adelman, RD | 2 |
Spangler, WL | 1 |
Beasom, F | 1 |
Ishizaki, G | 1 |
Conzelman, GM | 1 |
Oh, W | 1 |
Schwartz, ML | 1 |
Vogel, SB | 1 |
Gerkens, JF | 2 |
Branch, RA | 2 |
Brater, DC | 3 |
Chennavasin, P | 1 |
Seiwell, R | 1 |
Burdmann, EA | 1 |
Andoh, TF | 1 |
Nast, CC | 1 |
Evan, A | 1 |
Connors, BA | 1 |
Coffman, TM | 1 |
Lindsley, J | 1 |
Bennett, WM | 1 |
Moser, E | 1 |
Guo, JH | 1 |
Song, ST | 1 |
Xu, ZL | 1 |
Duda, SH | 1 |
Raible, RT | 1 |
Risler, T | 1 |
Huppert, PE | 1 |
Brambs, HJ | 1 |
Gregor, M | 1 |
Anand, AJ | 1 |
Bashey, B | 1 |
Vasuvattakul, S | 1 |
Gougoux, A | 1 |
Halperin, ML | 1 |
Hisatome, I | 1 |
Kato, T | 1 |
Miyakoda, H | 1 |
Takami, T | 1 |
Abe, T | 1 |
Tanaka, Y | 1 |
Kosaka, H | 1 |
Ogino, K | 1 |
Mitani, Y | 1 |
Yoshida, A | 1 |
Hwang, SJ | 1 |
Haas, M | 1 |
Harris, HW | 1 |
Silva, P | 1 |
Yalla, S | 1 |
Sullivan, MR | 1 |
Otuechere, G | 1 |
Kashgarian, M | 1 |
Zeidel, ML | 1 |
Takeda, M | 1 |
Jung, KY | 1 |
Sekine, T | 1 |
Endou, H | 1 |
Koide, H | 1 |
Huang, ZQ | 1 |
Sanders, PW | 2 |
Wu, MS | 1 |
Hong, JJ | 1 |
Lin, JL | 1 |
Yang, CW | 1 |
Chien, HC | 1 |
Köckerling, A | 1 |
Reinalter, SC | 1 |
Seyberth, HW | 3 |
Ptácek, P | 1 |
Vyhnálek, O | 1 |
Breuel, HP | 1 |
Macek, J | 1 |
Dana, R | 1 |
Kachhwaha, VS | 1 |
Bhatnagar, A | 1 |
Singh, AK | 1 |
Babbar, A | 1 |
Soni, NL | 1 |
Singh, T | 1 |
Romagnoli, C | 1 |
Zecca, E | 1 |
Papacci, P | 1 |
De Carolis, MP | 1 |
Giannini, R | 1 |
Gallini, F | 1 |
Tortorolo, G | 1 |
Eising, EG | 1 |
Bonzel, KE | 1 |
Zander, C | 1 |
Farahati, J | 1 |
Reiners, C | 1 |
Kolonko, A | 1 |
Kokot, F | 1 |
Wiecek, A | 1 |
Eades, SK | 1 |
Christensen, ML | 1 |
Stevens, MA | 1 |
McCullough, PA | 1 |
Tobin, KJ | 1 |
Speck, JP | 1 |
Westveer, DC | 1 |
Guido-Allen, DA | 1 |
Timmis, GC | 1 |
O'Neill, WW | 1 |
Shukla, AR | 1 |
Homsy, YL | 1 |
Heiba, S | 1 |
Salem, S | 1 |
Santiago, JF | 1 |
Goswami, G | 1 |
Jana, S | 1 |
Abdel-Dayem, HM | 1 |
Robertson, DG | 1 |
Reily, MD | 1 |
Sigler, RE | 1 |
Wells, DF | 1 |
Paterson, DA | 1 |
Braden, TK | 1 |
Nakahama, H | 2 |
Obata, K | 1 |
Sugita, M | 1 |
Oka, K | 1 |
Cohen, DJ | 1 |
Braunstein, RH | 1 |
Leveillee, RJ | 2 |
Lerner, I | 1 |
Sfakianakis, E | 1 |
Georgiou, MF | 1 |
Block, NL | 1 |
Lynne, CM | 1 |
Jeck, N | 1 |
Konrad, M | 1 |
Hess, M | 1 |
Rossleigh, MA | 1 |
Adeyoju, AA | 1 |
Burke, D | 1 |
Atkinson, C | 1 |
McKie, C | 1 |
Pollard, AJ | 1 |
Boughattas, S | 1 |
Hassine, H | 1 |
Chatti, K | 1 |
Jomaa, R | 1 |
Essabbah, H | 1 |
Gomez-Marin, O | 1 |
Rivas, LA | 1 |
Amendola, MA | 1 |
Aitio, ML | 1 |
Arkhipov, VV | 1 |
Papaian, AV | 1 |
Rivkin, AM | 1 |
Levicheva, OV | 1 |
Wilkinson, SP | 1 |
Wheeler, PG | 1 |
Smith, IK | 1 |
Williams, R | 1 |
Pasternack, A | 1 |
Pettersson, E | 1 |
Klockars, M | 1 |
Markenson, JA | 1 |
Sherman, RL | 1 |
Swartz, C | 1 |
Kim, KE | 1 |
Epstien, M | 1 |
Witkowska, M | 1 |
Benet, LZ | 1 |
Gallagher, KL | 1 |
Jones, JK | 1 |
Ratner, MIa | 1 |
Tomilina, NA | 1 |
Biriukova, LS | 1 |
Ojeda, VJ | 1 |
McMurtry, RJ | 2 |
Mitchell, JR | 3 |
Noël, P | 1 |
Levy, VG | 1 |
Leshchinskiĭ, LA | 1 |
Trusov, VV | 1 |
Pimenov, LT | 1 |
Naranjo, CA | 1 |
Busto, U | 1 |
Cassis, L | 1 |
Engle, MA | 1 |
Lewy, PR | 1 |
Metcoff, J | 1 |
Thomsen, J | 1 |
Bech, P | 1 |
Szpirt, W | 1 |
Birnbaum, M | 1 |
Weidmann, P | 1 |
Reubi, F | 1 |
Statham, CN | 1 |
Nelson, SD | 1 |
Atanasova, D | 1 |
Panitsa, D | 1 |
Andonova, S | 1 |
Vasileva, E | 1 |
Jollows, DJ | 1 |
Rodés, J | 1 |
Bosch, J | 1 |
Arroyo, V | 1 |
Birkenhäger, WH | 1 |
Wester, A | 1 |
Hall, KA | 1 |
Wong, RW | 1 |
Hunter, GC | 1 |
Camazine, BM | 1 |
Rappaport, WA | 1 |
Smyth, SH | 1 |
Bull, DA | 1 |
McIntyre, KE | 1 |
Bernhard, VM | 1 |
Misiorowski, RL | 1 |
Levy, M | 2 |
Cernacek, P | 1 |
Downing, GJ | 1 |
Egelhoff, JC | 1 |
Daily, DK | 1 |
Thomas, MK | 1 |
Alon, U | 1 |
Zawada, ET | 1 |
Wemyss-Holden, GD | 1 |
Payne, SR | 1 |
Booker, BB | 1 |
Shultz, PK | 1 |
Strife, JL | 1 |
Strife, CF | 1 |
McDaniel, JD | 1 |
Hernanz-Schulman, M | 1 |
Leonhardt, A | 1 |
Tönshoff, B | 1 |
Gordjani, N | 1 |
Iudin, LA | 1 |
Reznichenko, AA | 1 |
Uskov, IA | 1 |
Gol'dman, VE | 1 |
Ivanova, IuV | 1 |
Naryshkina, VM | 1 |
Budkevich, IuB | 1 |
Asher, JP | 1 |
Murray, KM | 1 |
Petion, AM | 1 |
Gouyon, JB | 1 |
Sandre, D | 1 |
Shichiri, M | 1 |
Itoh, H | 1 |
Iwamoto, H | 1 |
Hirata, Y | 1 |
Marumo, F | 1 |
Brown, AL | 1 |
Greenwood, RN | 1 |
Cattell, WR | 1 |
Aref'eva, AK | 1 |
Rykov, VA | 1 |
Mitrokhina, LN | 1 |
Tribble, KA | 1 |
Wilkinson, RH | 1 |
Beytas, EM | 1 |
Eisenberg, B | 1 |
Arrington, ER | 1 |
Mouchizadeh, J | 1 |
Gibel, LJ | 1 |
Larsson, R | 1 |
Karlberg, BE | 1 |
Gelin, A | 1 |
Aberg, J | 1 |
Regårdh, CG | 1 |
Bucher, JR | 1 |
Huff, J | 1 |
Haseman, JK | 1 |
Eustis, SL | 1 |
Davis, WE | 1 |
Meierhenry, EF | 1 |
Ueno, Y | 1 |
Masuyama, Y | 1 |
Guédon, J | 1 |
Howlett, MR | 1 |
Skellern, GG | 1 |
Auld, WH | 1 |
Murdoch, WR | 1 |
Donohoe, JF | 2 |
Laher, M | 1 |
Doyle, GD | 2 |
Cooper, WD | 1 |
Reznik, LV | 1 |
Bakhteeva, VT | 1 |
Myazina, EM | 1 |
Brovtsyn, VK | 1 |
Stockigt, JR | 1 |
Lim, CF | 1 |
Barlow, JW | 1 |
Wynne, KN | 1 |
Mohr, VS | 1 |
Topliss, DJ | 1 |
Hamblin, PS | 1 |
Sabto, J | 1 |
Schirmer, K | 1 |
Gläser, M | 1 |
Driscoll, DF | 2 |
Pinson, CW | 2 |
Jenkins, RL | 2 |
Bistrian, BR | 2 |
Mondorf, AW | 1 |
Bonsiepe, C | 1 |
Mondorf, W | 1 |
Kelly, J | 1 |
Laher, MS | 1 |
Sowers, JR | 1 |
Beck, FW | 1 |
Waters, BK | 1 |
Barrett, JD | 1 |
Welch, BG | 1 |
Reams, GP | 1 |
Bauer, JH | 1 |
Dahl, K | 1 |
Hellum, KB | 1 |
Thurmann-Nielsen, E | 1 |
Myracle, MR | 1 |
McGahan, JP | 1 |
Goetzman, BW | 1 |
Rombolà, G | 1 |
Colussi, G | 1 |
De Ferrari, ME | 1 |
Surian, M | 1 |
Malberti, F | 1 |
Minetti, L | 1 |
Cirera, L | 1 |
Gay, M | 1 |
Tomé, T | 1 |
Martí, M | 1 |
Huguet, J | 1 |
Plá, R | 1 |
Miwa, Y | 1 |
Yamaji, A | 1 |
Orita, Y | 1 |
Fukuhara, Y | 1 |
Kamada, T | 1 |
Ishibashi, M | 1 |
Ichikawa, Y | 1 |
Takahara, S | 1 |
Sonoda, T | 1 |
Jacinto, JS | 1 |
Modanlou, HD | 1 |
Crade, M | 1 |
Strauss, AA | 1 |
Bosu, SK | 1 |
Heering, P | 1 |
Westhoff, A | 1 |
Bach, D | 1 |
Sprenger, KB | 1 |
Passlick, J | 1 |
Helmchen, U | 1 |
Grabensee, B | 1 |
Singh, A | 1 |
Gupta, U | 1 |
Sagar, S | 1 |
Garg, SK | 1 |
Sharma, BK | 1 |
Mathur, VS | 1 |
Gray, JA | 1 |
Kavlock, RJ | 1 |
Imnaishvili, GM | 1 |
Vargas-Origel, A | 1 |
Cruz-Anguiano, V | 1 |
López-Montaño, E | 1 |
Whitfield, HN | 1 |
Britton, KE | 1 |
Hendry, WF | 1 |
Wickham, JE | 1 |
Heidemann, HT | 1 |
Jackson, EK | 1 |
Pupita, F | 1 |
Campolucci, G | 1 |
Pulido, M | 1 |
Belogi, M | 1 |
Rotatori, P | 1 |
Ansuini, R | 1 |
Frausini, G | 1 |
Barone, A | 1 |
Gaggi, S | 1 |
Harrold, BP | 1 |
Manku, MS | 2 |
Nassar, BA | 2 |
Horrobin, DF | 2 |
Radó, JP | 2 |
Bános, C | 1 |
Takó, J | 2 |
Fairley, KF | 1 |
Groover, ME | 1 |
Fulghum, JE | 1 |
Simpson, WG | 1 |
Deilmann, W | 1 |
Gross, F | 1 |
Lamprecht, F | 1 |
Ziegler, M | 1 |
Fyhrquist, F | 1 |
Kala, R | 1 |
Eisalo, A | 1 |
Muth, RG | 3 |
Imhof, PR | 2 |
Hushak, J | 1 |
Schumann, G | 1 |
Dukor, P | 1 |
Wagner, J | 1 |
Keller, HM | 1 |
Nakagawa, S | 1 |
Yamada, T | 1 |
Kitaoka, T | 1 |
Koshikawa, S | 1 |
Ch'en, CL | 1 |
Giese, J | 1 |
Aurell, M | 1 |
Munck, O | 1 |
Ben-Ishay, D | 1 |
Birnbaum, D | 1 |
Wieck, HH | 1 |
Ulrich, G | 1 |
Lowenthal, DT | 1 |
Shear, L | 1 |
Nigrovic, V | 1 |
Koechel, DA | 1 |
Cafruny, EJ | 1 |
Cummings, YE | 1 |
Dillard, MG | 1 |
Seedat, YK | 1 |
Jahrmärker, H | 1 |
Olsson, CA | 1 |
Moyer, JD | 1 |
Chute, R | 1 |
Weily, HS | 1 |
Genton, E | 1 |
Stenbaek, O | 1 |
Szende, L | 2 |
Radó, J | 1 |
Reubi, FC | 1 |
Cohn, JN | 1 |
Tristani, FE | 1 |
Khatri, IM | 1 |
Cruz, J | 1 |
Mattar, E | 1 |
Cruz, HM | 1 |
Nanninga, JB | 1 |
Deam, M | 1 |
Holland, JM | 1 |
Grayhack, JT | 1 |
Sandstead, HH | 1 |
Michelakis, AM | 1 |
Temple, TE | 1 |
Schwartz, GH | 1 |
David, DS | 1 |
Riggio, RR | 1 |
Stenzel, KH | 1 |
Rubin, AL | 1 |
Paleeva, FM | 1 |
Makarova, NA | 1 |
Scarpioni, L | 1 |
Carrara, GC | 1 |
Lawson, DH | 1 |
Macadam, RF | 1 |
Singh, H | 1 |
Gavras, H | 1 |
Linton, AL | 1 |
Buckalew, VM | 1 |
Zaleski, A | 1 |
Rancewicz, Z | 1 |
Lao, M | 1 |
Klütsch, K | 1 |
Joynt, MS | 1 |
Morrin, PA | 1 |
Onen, K | 1 |
Obek, A | 1 |
López de Novales, E | 1 |
Avendaño, L | 1 |
Gutmann, FD | 1 |
Shelp, WD | 1 |
Rieselbach, RE | 1 |
Scheler, F | 1 |
Quellhorst, E | 1 |
Höffler, D | 1 |
Wigger, W | 1 |
Barranco, M | 1 |
Carneado, J | 1 |
Andreu Kern, F | 1 |
Hunt, JC | 1 |
Maher, FT | 1 |
Jahnecke, J | 2 |
Sökeland, J | 1 |
Schmidt, AW | 1 |
Krück, F | 2 |
Kuzmanic, A | 1 |
Faivovich, A | 1 |
Del Rio, R | 1 |
Jaruffe, F | 1 |
Vera, Y | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Chinese People's Liberation Army General Hospital[NCT02405377] | 264 participants (Actual) | Interventional | 2014-02-28 | Completed | |||
Effect of Acetazolamide and Furosemide on Obesity-induced Glomerular Hyperfiltration[NCT01146288] | 13 participants (Actual) | Interventional | 2010-07-31 | Completed | |||
A Randomized, Placebo-Controlled, Double-Blind, Multi-Center, Parallel Group, Single Dose Study to Evaluate Cardiac Hemodynamics and Safety During Right Heart Catheterization of Three IV Doses of SLV320 in Subjects With Congestive Heart Failure Requiring [NCT00160134] | Phase 2 | 0 participants | Interventional | 2005-01-31 | Completed | ||
"Early and Late Timing Indication for Starting Renal Replacement Therapy in Acute Renal Failure After Cardiac Surgery: a Prospective, Controlled, Interventional, Single-center Trial"[NCT01961999] | 1,800 participants (Actual) | Interventional | 2011-07-31 | Completed | |||
A Phase II Randomized Blinded Controlled Trial of the Effect of furoSemide in Critically Ill Patients With eARly Acute Kidney Injury (The SPARK Study)[NCT00978354] | Phase 2/Phase 3 | 72 participants (Actual) | Interventional | 2009-09-30 | Terminated (stopped due to Feasibility of target enrollment within the context of available funding resources.) | ||
Phase III Study of Furosemide Continuous Infusion Versus Ethacrynic Acid Continuous Infusion in Children Undergoing Cardiac Surgery: Randomized Double Blind Controlled Clinical Trial[NCT01628731] | Phase 3 | 74 participants (Actual) | Interventional | 2012-10-31 | Completed | ||
Renal Insufficiency Following Contrast Media Administration Trial II (Remedial II): The RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury[NCT01098032] | Phase 3 | 294 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
A Study to Evaluate the Effectiveness of Induced Diuresis With Matched Hydration Therapy Compared to Standard Overnight Hydration in the Prevention of Contrast Induced Nephropathy -MYTHOS Study[NCT00702728] | Phase 3 | 120 participants (Anticipated) | Interventional | 2008-06-30 | Recruiting | ||
Renal Insufficiency Following Contrast Media Administration Trial III (REMEDIAL III): Renalguard System Versus Left-ventricular End-diastolic Pressure-guided Hydration in High-risk Patients for Contrast-induced Acute Kidney Injury[NCT02489669] | 700 participants (Anticipated) | Interventional | 2015-07-15 | Enrolling by invitation | |||
Effect of Hydration Guided by Vigileo on the Prevention of Contrast Induced Nephropathy After Emergency PCI for Patients With Acute Myocardial Infarction[NCT04382313] | 344 participants (Actual) | Interventional | 2020-07-10 | Completed | |||
Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial[NCT03923933] | Phase 2 | 34 participants (Actual) | Interventional | 2019-06-18 | Completed | ||
Reliability and Utility of Fluid Balance Charting in Neonates Admitted to the Pediatric Ward.[NCT00962754] | Phase 4 | 170 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
Efficacy of Oral Sodium Chloride vs iv Sodium Chloride in the Prevention of Contrast Nephropathy in Outpatients[NCT03476460] | Phase 2 | 269 participants (Actual) | Interventional | 2014-03-01 | Completed | ||
Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease (ENRICH): A Randomized Controlled Trial[NCT05283512] | 254 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | |||
Utilization of Furosemide to Expedite Bladder Filling in Pediatric Females With Suspected Ovarian Torsion Awaiting Pelvic Ultrasound[NCT05098366] | Early Phase 1 | 100 participants (Anticipated) | Interventional | 2021-05-29 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
(NCT01146288)
Timeframe: baseline and after diuretics administration
Intervention | ml/min (Mean) | |
---|---|---|
GFR before acetazolamide/furosemide administration | GFR after acetazolamide/furosemide administration | |
Acetazolamide | 151 | 120 |
Furosemide | 152 | 150 |
(NCT01146288)
Timeframe: baseline and after diuretics administration
Intervention | mm Hg/[ml/min] (Mean) | |
---|---|---|
before acetazolamide/furosemide administration | after acetazolamide/furosemide administration | |
Acetazolamide | 0.078 | 0.088 |
Furosemide | 0.073 | 0.080 |
The primary outcome measure will be the rate of development of CI-AKI in the 2 study arms (number of participants). CI-AKI is defined as an increase in the serum creatinine concentration >=0.3 mg/dL from the baseline value at 48 hours after administration of the contrast media or the need for dialysis. (NCT01098032)
Timeframe: at 48 hours following contrast exposure
Intervention | participants (Number) |
---|---|
Systemic Alone Therapy Group | 146 |
RenalGuard System Group | 146 |
(NCT03923933)
Timeframe: Change from Basal to day 28
Intervention | mmHg (Mean) |
---|---|
Placebo | -3.4 |
Treatment Grup | -13.5 |
Decrease in extracellular water measured by bioelectrical impedance analysis (NCT03923933)
Timeframe: Change from Basal to day 28
Intervention | litres (Mean) |
---|---|
Placebo | -0.15 |
Treatment Grup | 2.55 |
Decrease in extracellular water / total body water ratio measured by bioelectrical impedance analysis (NCT03923933)
Timeframe: Change from Basal to day 28
Intervention | percentage of ECW/TBW (Mean) |
---|---|
Placebo | -0.24 |
Treatment Grup | -2.92 |
decrease in blood pressure compared wit baseline measure (mmhg) (NCT03923933)
Timeframe: Change from Basal to day 28
Intervention | mmHg (Mean) |
---|---|
Placebo | -5.4 |
Treatment Grup | -18.1 |
(NCT03923933)
Timeframe: Change from Basal to day 28
Intervention | mmHg (Mean) |
---|---|
Placebo | -10 |
Treatment Grup | -26.1 |
Increase in the fractional excretion of sodium compared with the baseline measure (NCT03923933)
Timeframe: Change from Basal to day 28
Intervention | percentage of sodium excreted (Mean) |
---|---|
Placebo | -0.348 |
Treatment Grup | 0.598 |
Measured by bioelectrical impedance analysis, compared to the initial measurement (NCT03923933)
Timeframe: Change from Basal to day 28
Intervention | litres (Mean) |
---|---|
Placebo | -0.075 |
Treatment Grup | -4.36 |
notifications of complications (NCT00962754)
Timeframe: duration of admission
Intervention | participants (Number) |
---|---|
Physician Insight Fluid Balance | 2 |
Physician no Insight Fluid Balance Chart | 5 |
Duration of hospital stay in days or duration of admission at the pediatric ward in days (NCT00962754)
Timeframe: 1-8 months
Intervention | number of days (Median) |
---|---|
Intervention Group (no Insight in Fluid Balance) | 9 |
Control Group (Insight in Fluid Balance) | 8 |
prescription of diuretic therapy (NCT00962754)
Timeframe: during days of admission
Intervention | participants (Number) |
---|---|
Intervention Group (no Insight in Fluid Balance) | 0 |
Control Group (Insight in Fluid Balance) | 0 |
29 reviews available for furosemide and Kidney Diseases
Article | Year |
---|---|
Chronobiology in nephrology: the influence of circadian rhythms on renal handling of drugs and renal disease treatment.
Topics: Angiotensin Receptor Antagonists; Animals; Anti-Bacterial Agents; Antimetabolites, Antineoplastic; B | 2018 |
Furosemide with saline hydration for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a meta-analysis of randomized controlled trials.
Topics: Aged; Contrast Media; Coronary Angiography; Female; Fluid Therapy; Furosemide; Humans; Kidney Diseas | 2015 |
Adenosine A1 antagonists and the cardiorenal syndrome.
Topics: Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug | 2008 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast | 2011 |
A review of pharmacologic interventions to prevent contrast-induced nephropathy.
Topics: Acetylcysteine; Adenosine; Calcium Channel Blockers; Contrast Media; Creatinine; Fenoldopam; Furosem | 2003 |
[The patient with edema of the legs].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Creatinine; Diagnosis, Differential; Diuretics; Drug Th | 2004 |
[Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].
Topics: Bone Density; Bone Diseases, Metabolic; Calcitonin; Chronic Disease; Diphosphonates; Epoxy Compounds | 2004 |
Management of hypertension in chronic kidney disease.
Topics: Algorithms; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chronic Dise | 2006 |
Kidney-ear axis.
Topics: Antineoplastic Agents; Branchio-Oto-Renal Syndrome; Carrier Proteins; Cisplatin; Comorbidity; Diuret | 2007 |
[Hepatorenal syndrome. Clinical and pathogenetic aspects and therapeutic approach].
Topics: Dihydroergotoxine; Dopamine; Endotoxins; Furosemide; Hemodynamics; Humans; Kidney Diseases; Liver Ci | 1984 |
Pathogenesis and management of hemolytic transfusion reactions.
Topics: Antibodies; Blood Group Incompatibility; Complement System Proteins; Dose-Response Relationship, Imm | 1981 |
Sodium and hypertension. A review of the role of sodium in pathogenesis and the action of diuretic drugs.
Topics: Age Factors; Aldosterone; Amiloride; Benzothiadiazines; Diuretics; Furosemide; Humans; Hypertension; | 1980 |
[Treatment of children with diuretics, particularly furosemide].
Topics: Adolescent; Child; Child, Preschool; Diuresis; Diuretics; Edema; Furosemide; Humans; Infant; Infant, | 1980 |
Diuretics in infancy.
Topics: Acute Disease; Benzothiadiazines; Diet, Sodium-Restricted; Diuretics; Diuretics, Osmotic; Edema; Eth | 1981 |
Newer insights into cisplatin nephrotoxicity.
Topics: Amifostine; Animals; Cisplatin; Furosemide; Glutathione; Humans; Kidney Diseases; Male; Mannitol; So | 1993 |
The clinical pharmacology of loop diuretics in the pediatric patient.
Topics: Bumetanide; Child; Diuretics; Drug Resistance; Drug Tolerance; Furosemide; Humans; Kidney Diseases; | 1998 |
[Role of scintigraphic tests in upper urinary tract dilatation in children].
Topics: Child; Child, Preschool; Diagnosis, Differential; Dilatation, Pathologic; Diuretics; False Positive | 2002 |
[Protecting kidneys from radiocontrast toxicity--do fluids or drugs help?].
Topics: Calcium Channel Blockers; Clinical Trials as Topic; Contrast Media; Diuretics; Diuretics, Osmotic; F | 1999 |
Deranged renal function in liver disease.
Topics: Angiotensin II; Diet, Sodium-Restricted; Furosemide; Humans; Hyperaldosteronism; Kidney; Kidney Dise | 1977 |
[Clinical pharmacology of furosemide].
Topics: Adult; Age Factors; Animals; Blood Proteins; Child, Preschool; Furosemide; Humans; Kidney; Kidney Di | 1977 |
[Kidney and pregnancy].
Topics: Acute Kidney Injury; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Chloramphenicol; Creatin | 1976 |
[Renal hypertension].
Topics: Aldosterone; Angiotensin II; Diuretics; Furosemide; Glomerulonephritis; Humans; Hypercalcemia; Hyper | 1976 |
Prostanoids in paediatric kidney diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Cyclosporine; Eicosanoids; Furosemide; Glucocorticoi | 1991 |
Use of angiotensin-converting-enzyme inhibitors in the management of renal disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Connective Tissue Diseases; Diabetic Nephropathies; Furose | 1991 |
Disposition and response to bumetanide and furosemide.
Topics: Adult; Aged; Biological Availability; Bumetanide; Diuretics; Furosemide; Heart Failure; Humans; Kidn | 1986 |
Resistance to loop diuretics. Why it happens and what to do about it.
Topics: Anti-Inflammatory Agents; Diet, Sodium-Restricted; Diuretics; Drug Interactions; Drug Resistance; Fu | 1985 |
[Dynamics of water and sodium in renal insufficiency: in reference to therapeutic classification of disease stages].
Topics: Adolescent; Adult; Aldosterone; Diuretics; Furosemide; Humans; Kidney Concentrating Ability; Kidney | 1974 |
[Clinical use of diuretics].
Topics: Acid-Base Equilibrium; Benzothiadiazines; Diuretics; Ethacrynic Acid; Furosemide; Hearing Disorders; | 1974 |
[When and which diuretics? General and specific indications for diuretic therapy].
Topics: Acid-Base Equilibrium; Brain Edema; Diuresis; Diuretics; Edema; Ethacrynic Acid; Furosemide; Humans; | 1971 |
36 trials available for furosemide and Kidney Diseases
Article | Year |
---|---|
A risk prediction model for contrast-induced nephropathy associated with gadolinium-based contrast agents.
Topics: Albumins; Blood Glucose; Contrast Media; Female; Furosemide; Gadolinium; Humans; Kidney Diseases; Ma | 2022 |
Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial.
Topics: Antineoplastic Agents; Cisplatin; Clinical Trials, Phase II as Topic; Creatinine; Diuretics; Drug Th | 2019 |
Randomized study comparing mannitol with furosemide for the prevention of cisplatin-induced renal toxicity in non-small cell lung cancer: The OLCSG1406 trial.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Combinations; Female; Furosemide; Human | 2021 |
Effects of Additive Tolvaptan vs. Increased Furosemide on Heart Failure With Diuretic Resistance and Renal Impairment - Results From the K-STAR Study.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Diuretics; Dose-Response Relatio | 2017 |
Massive Proteinuria-Induced Injury of Tubular Epithelial Cells in Nephrotic Syndrome is Not Exacerbated by Furosemide.
Topics: Adolescent; Adult; Biomarkers; Case-Control Studies; Cell Line; Cell Survival; Child; Epithelial Cel | 2018 |
Low-dose furosemide administered with adequate hydration reduces contrast-induced nephropathy in patients undergoing coronary angiography.
Topics: Adult; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Contrast Media; Cor | 2013 |
Efficacy of tolvaptan added to furosemide in heart failure patients with advanced kidney dysfunction: a pharmacokinetic and pharmacodynamic study.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; | 2015 |
Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Diuretics; Furosemide; Glomerular Filtration Ra | 2015 |
Acetazolamide and Hydrochlorothiazide Followed by Furosemide Versus Furosemide and Hydrochlorothiazide Followed by Furosemide for the Treatment of Adults With Nephrotic Edema: A Randomized Trial.
Topics: Acetazolamide; Adult; Diuretics; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Furo | 2017 |
Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Topics: Adenosine A1 Receptor Antagonists; Cardiovascular Agents; Cyclohexanes; Diuresis; Diuretics; Dose-Re | 2009 |
Furosemide infusion prevents the requirement of renal replacement therapy after cardiac surgery.
Topics: Adult; Aged; Coronary Artery Bypass; Creatinine; Diabetes Mellitus; Diuresis; Diuretics; Female; Fur | 2009 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.
Topics: Acetylcysteine; Acute Kidney Injury; Biomarkers; Chi-Square Distribution; Chronic Disease; Contrast | 2011 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
Topics: Acute Kidney Injury; Aged; Confidence Intervals; Contrast Media; Creatinine; Diuretics; Female; Flui | 2012 |
A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease.
Topics: Aged; Anthropology; Biological Availability; Blood Pressure; Chronic Disease; Diet Records; Diuretic | 2012 |
Flow-mediated K(+) secretion in horses intoxicated with lolitrem B (perennial ryegrass staggers).
Topics: Animals; Diuretics; Female; Furosemide; Horse Diseases; Horses; Indole Alkaloids; Kidney; Kidney Dis | 2013 |
Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Cross-Over Studies; Diuretics; Double | 2003 |
Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Cisplatin; Creatinine; Diuretics; Drug Therapy, Com | 2003 |
Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass.
Topics: Aged; Aged, 80 and over; Biomarkers; Cardiopulmonary Bypass; Creatinine; Diuretics; Dopamine Agonist | 2003 |
Mannitol and dopamine in patients undergoing cardiopulmonary bypass: a randomized clinical trial.
Topics: Adult; Aged; beta 2-Microglobulin; Blood Pressure; Cardiopulmonary Bypass; Cardiotonic Agents; Creat | 2003 |
Use of fenoldopam to control renal dysfunction early after liver transplantation.
Topics: Adult; Antibodies, Monoclonal; Basiliximab; Creatinine; Cyclosporine; Dopamine; Dopamine Agonists; D | 2004 |
Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial.
Topics: Acute Kidney Injury; Adult; Aged; Blood Urea Nitrogen; Blood Volume; Cyclosporine; Diuretics; Dopami | 2004 |
Effectiveness of diuretic injection on the measurement of differential renal function using Tc-99m DMSA in patients with a dilated renal pelvis.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Furosemide; Humans; Infant; Injections; Kidney D | 2005 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Topics: Administration, Oral; Aged; Contrast Media; Creatinine; Diabetic Nephropathies; Diuretics; Drug Syne | 2006 |
[Clinical comparative trial of piretanide and furosemide in patients with advanced renal insufficiency. Drug levels and diuretic potency of single oral doses].
Topics: Aged; Creatinine; Diuretics; Electrolytes; Female; Furosemide; Humans; Kidney Diseases; Male; Middle | 1983 |
Effect of xipamide in oedema of renal disease with varying degrees of renal insufficiency: a comparative trial with frusemide.
Topics: Adolescent; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Diuretics; Edema; Female; Furosem | 1982 |
Diuresis in the ascitic patient: a randomized controlled trial of three regimens.
Topics: Ascites; Body Weight; Clinical Trials as Topic; Drug Therapy, Combination; Female; Furosemide; Hepat | 1981 |
Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus.
Topics: Drug Therapy, Combination; Ductus Arteriosus, Patent; Furosemide; Humans; Indomethacin; Infant, Newb | 1982 |
Impaired response to furosemide in hyperprostaglandin E syndrome: evidence for a tubular defect in the loop of Henle.
Topics: Bartter Syndrome; Dinoprostone; Diuretics; Furosemide; Humans; Indomethacin; Kidney Diseases; Loop o | 1996 |
Determination of furosemide in plasma and urine by gas chromatography/mass spectrometry.
Topics: Bumetanide; Calibration; Diuretics; Furosemide; Gas Chromatography-Mass Spectrometry; Half-Life; Hum | 1996 |
Comparison of oral and intravenous hydration and diuretic, choice for protecting cisplatin induced nephrotoxicity.
Topics: Administration, Oral; Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Diuretics, | 1996 |
Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.
Topics: Body Weight; Cyclooxygenase Inhibitors; Diuretics; Ductus Arteriosus, Patent; Female; Furosemide; Ge | 1997 |
A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.
Topics: Aged; Cardiotonic Agents; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Crysta | 1999 |
A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.
Topics: Aged; Cardiotonic Agents; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Crysta | 1999 |
A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.
Topics: Aged; Cardiotonic Agents; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Crysta | 1999 |
A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.
Topics: Aged; Cardiotonic Agents; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Crysta | 1999 |
Randomized multi center study comparing nephrotoxicity of ceftazidime versus the combination of piperacillin and netilmicin with and without furosemide.
Topics: Aged; Alanine Transaminase; Ceftazidime; Creatinine; Drug Combinations; Female; Furosemide; Humans; | 1989 |
Comparative bioequivalence study of furosemide in patients with edema of renal origin.
Topics: Adult; Diuresis; Edema; Female; Furosemide; Humans; Kidney Diseases; Male; Middle Aged; Therapeutic | 1987 |
Excretion of urinary casts after the administration of diuretics.
Topics: Chemical Precipitation; Chlorthalidone; Clinical Trials as Topic; Diuresis; Diuretics; Ethacrynic Ac | 1972 |
214 other studies available for furosemide and Kidney Diseases
Article | Year |
---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological | 2010 |
Diuretic and Renal Protective Effect of Kaempferol 3-
Topics: Animals; Antioxidants; Bauhinia; Calcium; Chlorides; Cyclooxygenase Inhibitors; Diuretics; Hypertens | 2020 |
Biomarkers in neonates receiving potential nephrotoxic drugs.
Topics: Acetaminophen; Adult; Amikacin; Biomarkers; Cystatins; Female; Furosemide; Gentamicins; Hepatitis A | 2021 |
Effects of early diuretic response to carperitide in acute decompensated heart failure treatment: A single-center retrospective study.
Topics: Aged; Atrial Natriuretic Factor; Blood Urea Nitrogen; Body Mass Index; Diuretics; Female; Furosemide | 2018 |
Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention.
Topics: Aged; Biomarkers; C-Reactive Protein; Contrast Media; Coronary Artery Disease; Creatinine; Female; F | 2019 |
Heart failure and diuretic treatment.
Topics: Creatinine; Diuretics; Furosemide; Heart Failure; Humans; Kidney Diseases; Sodium Potassium Chloride | 2013 |
The importance of uromodulin as regulator of salt reabsorption along the thick ascending limb.
Topics: Diuretics; Female; Furosemide; Humans; Kidney Diseases; Male; Mutation; Uromodulin | 2015 |
Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Chronic Disease; Creatinine; Di | 2016 |
Paradoxical response to furosemide in uromodulin-associated kidney disease.
Topics: Adult; Diuretics; Female; Furosemide; Genetic Predisposition to Disease; Genetic Testing; Humans; Ki | 2015 |
A combined clinical and biomarker approach to predict diuretic response in acute heart failure.
Topics: Acute Disease; Atherosclerosis; Biomarkers; Clinical Trials, Phase III as Topic; Diuretics; Electrol | 2016 |
Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
Topics: Aged; Aged, 80 and over; Chronic Disease; Dose-Response Relationship, Drug; Female; Furosemide; Glom | 2016 |
[Simultaneous determination of four drugs for kidney diseases in urine by high performance liquid chromatography].
Topics: Chromatography, High Pressure Liquid; Enalapril; Furosemide; Humans; Kidney Diseases; Triamterene; V | 2015 |
A retrospective evaluation of furosemide and mannitol for prevention of cisplatin-induced nephrotoxicity.
Topics: Adult; Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Diuretics; Female; Furosemide; Humans; K | 2017 |
[The quantitative measurement of the echogenicity of the renal parenchyma].
Topics: Adult; Diuretics; Female; Furosemide; Humans; Image Processing, Computer-Assisted; Imaging, Three-Di | 2008 |
[Functional MR urography in children].
Topics: Adult; Age Factors; Body Weight; Child, Preschool; Contrast Media; Diuretics; Female; Furosemide; Ga | 2009 |
Furosemide in preterm infants treated with indomethacin for patent ductus arteriosus.
Topics: Cohort Studies; Creatinine; Cyclooxygenase Inhibitors; Diuretics; Ductus Arteriosus, Patent; Female; | 2009 |
A renal protocol for all ages and all indications: mercapto-acetyl-triglycine (MAG3) with simultaneous injection of furosemide (MAG3-F0): a 17-year experience.
Topics: Adult; Child; Child, Preschool; Creatinine; Diuretics; Female; Furosemide; Humans; Infant; Infant, N | 2009 |
Predictors of "worsening renal function" in patients hospitalized in internal medicine department.
Topics: Aged; Creatinine; Diuretics; Female; Furosemide; Hospital Departments; Hospitals, Public; Humans; Hy | 2009 |
Clinical quiz. Page kidney in an adolescent with recent onset of hypertension and slightly decreased renal function. Ureteropelvic junction obstruction.
Topics: Adolescent; Carbonated Beverages; Diuretics; Furosemide; Hematoma; Humans; Hypertension, Renal; Kidn | 2010 |
Compartmental modelling for magnetic resonance renography.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Computer Simulation; Cyclooxygenase I | 2010 |
In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
Topics: Aged; Aged, 80 and over; Algorithms; Analysis of Variance; Biomarkers; Case-Control Studies; Chronic | 2011 |
Amlodipine and loop diuretics as the second anti-hypertensive medication for the treatment of hypertension with chronic kidney diseases.
Topics: Aged; Amlodipine; Angiotensin II Type 2 Receptor Blockers; Antihypertensive Agents; Blood Pressure; | 2011 |
Value of combined thiazide-loop diuretic therapy in chronic kidney disease: heart failure and renin-angiotensin-aldosterone blockade.
Topics: Blood Pressure; Female; Furosemide; Humans; Hydrochlorothiazide; Hypertension; Kidney Diseases; Male | 2012 |
Diuretic agent and normal saline infusion technique for ultrasound-guided percutaneous nephrostomies in nondilated pelvicaliceal systems.
Topics: Adult; Aged; Aged, 80 and over; Diuretics; Female; Furosemide; Humans; Iatrogenic Disease; Kidney Ca | 2013 |
Sonographic measurement of diuretic-induced renal length changes: are they correlated with renal function?
Topics: Adolescent; Child; Child, Preschool; Diuretics; Female; Furosemide; Humans; Infant; Kidney Diseases; | 2012 |
US and MRI in renal obstruction evaluation.
Topics: Dilatation, Pathologic; Diuretics; Furosemide; Glomerular Filtration Rate; Humans; Kidney Diseases; | 2002 |
Reverse pharmacological effect of loop diuretics and altered rBSC1 expression in rats with lithium nephropathy.
Topics: Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Dehydration; Diuretics; Furosem | 2003 |
Influence of early furosemide injection on the split renal function.
Topics: Adolescent; Algorithms; Artifacts; Child; Child, Preschool; Female; Furosemide; Humans; Infant; Infa | 2003 |
Analysis of compartmental models of type 4 nuclear renograms with calculation of flow rate parameters and instantaneous drainage rates.
Topics: Computer Simulation; Diuretics; Furosemide; Humans; Kidney; Kidney Diseases; Models, Biological; Rad | 2003 |
Monitoring hyperhydration during high-dose chemotherapy: body weight or fluid balance?
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Body Water; Body Weight; Cohort Studies; Confounding | 2003 |
Calculating the renal output efficiency as a method for clarifying equivocal renograms in adults with suspected upper urinary tract obstruction.
Topics: Adult; Constriction, Pathologic; Dilatation, Pathologic; Diuresis; Diuretics; Furosemide; Humans; Ki | 2003 |
A TOXICOLOGICAL EVALUATION OF FUROSEMIDE: A NEW DIURETIC AGENT.
Topics: Calcinosis; Diuretics; Dogs; Furosemide; Kidney Diseases; Pathology; Pharmacology; Research; Toxicol | 1964 |
[RENAL HEMODYNAMICS, WATER AND ELECTROLYTE ELIMINATION AFTER 4-CHLORO-N-(2-FURYLETHYL)-5-SULFAMOYLANTHRANILIC ACID].
Topics: Biomedical Research; Diuretics; Electrolytes; Furans; Furosemide; Glomerular Filtration Rate; Hemody | 1964 |
EXPERIENCES WITH FUROSEMIDE IN RENAL DISEASE.
Topics: Biomedical Research; Blood Urea Nitrogen; Creatine; Creatinine; Diabetic Nephropathies; Diuretics; D | 1965 |
[PRACTICAL EXPERIENCES WITH LASIX, A NEW SALURETIC].
Topics: Diuretics; Drug Therapy; Edema; Furosemide; Heart Failure; Humans; Kidney Diseases | 1965 |
[SITE AND MECHANISM OF ACTION OF FUROSEMIDE IN THE DISTAL NEPHRON IN HUMANS].
Topics: Biomedical Research; Diuretics; Furosemide; Kidney Diseases; Kidney Function Tests; Kidney Glomerulu | 1964 |
[Value of the diuretic isotopic renogram in the follow-up of the upper urinary tract after cystectomy and urinary diversion using intestine].
Topics: Cystectomy; Dilatation, Pathologic; Diuretics; Follow-Up Studies; Furosemide; Humans; Ileum; Kidney | 2003 |
Diuretic renography in late occurrence of hematoma after renal transplantation.
Topics: Diagnosis, Differential; Diuretics; Diverticulum; Furosemide; Hematoma; Humans; Kidney Diseases; Kid | 2004 |
Phenotype and genotype of Dent's disease in three Korean boys.
Topics: Arginine; Asian People; Child; Child, Preschool; Chloride Channels; Codon, Nonsense; Diuretics; Furo | 2005 |
[Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].
Topics: Bilirubin; Cholestasis; Creatinine; Diet, Sodium-Restricted; Diuresis; Diuretics; Furosemide; Glomer | 2005 |
Management of hypertension in patients with CKD: differences between primary and tertiary care settings.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzy | 2005 |
Management of renal problems in Australian general practice.
Topics: Adult; Age Distribution; Aged; Antacids; Australia; Calcium Carbonate; Diuretics; Erythropoietin; Fa | 2005 |
Diagnosis of a case of Gitelman's syndrome based on renal clearance studies and gene analysis of a novel mutation of the thiazide-sensitive Na-Cl cotransporter.
Topics: Adult; Amino Acid Sequence; Calcium; Chlorides; Furosemide; Heterozygote; Humans; Hypokalemia; Kidne | 2005 |
CT urography: a comparison of strategies for upper urinary tract opacification.
Topics: Adolescent; Adult; Aged; Butylscopolammonium Bromide; Contrast Media; Female; Furosemide; Hematuria; | 2007 |
3D excretory MR urography: improved image quality with intravenous saline and diuretic administration.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Diuretics; Furosemide; Gadolinium; Humans; Imaging, | 2007 |
A veno-caliceal fistula related to ureteric stricture in a kidney allograft masquerading as renal failure.
Topics: Contrast Media; Diagnosis, Differential; Diuretics; False Negative Reactions; Furosemide; Humans; Ki | 2007 |
[A rare cause of peripheral edema: exudative lymphocytic gastritis induced hypoprotidemia].
Topics: Aged; Diuretics; Duodenum; Edema; Female; Furosemide; Gastric Mucosa; Gastritis, Hypertrophic; Gastr | 2007 |
Drug-drug interactions with systemic antifungals in clinical practice.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Creatinine; Cyclosporine; Drug Interactions; Female; | 2007 |
Paralytic ileus as a complication of iatrogenic hypermagnesaemia without renal dysfunction.
Topics: Abdominal Pain; Aged; Antacids; Calcium Gluconate; Diuretics; Furosemide; Humans; Iatrogenic Disease | 2008 |
[Saluretics in the treatment of cardiac and renal edema].
Topics: Blood Circulation; Body Weight; Chlorothiazide; Diuretics; Edema; Ethacrynic Acid; Furosemide; Heart | 1966 |
Lasix.
Topics: Diuresis; Edema; Furosemide; Heart Failure; Humans; Kidney Diseases; Liver Cirrhosis; Potassium Defi | 1967 |
[The behavior of uricemia during treatment with spironolactone and with other diuretics].
Topics: Acetazolamide; Adolescent; Adult; Aged; Chlorthalidone; Clopamide; Diuretics; Ethacrynic Acid; Femal | 1967 |
[Method of determining the genesis of proteinuria (the furosemide proteinuric test)].
Topics: Adult; Female; Furosemide; Humans; Kidney Diseases; Male; Methods; Middle Aged; Proteinuria | 1983 |
Renal nuclear imaging and analysis in pediatric patients.
Topics: Diuretics; Female; Furosemide; Glomerular Filtration Rate; Humans; Hydronephrosis; Infant; Infant, N | 1980 |
Toxicology of cefotaxime in comparison to other cephalosporins.
Topics: Animals; Cefotaxime; Cephalosporins; Dogs; Drug Interactions; Female; Furosemide; Kidney Diseases; L | 1980 |
Radionuclides in the evaluation of urinary obstruction.
Topics: Adult; Aged; Female; Furosemide; Humans; Iodine Radioisotopes; Iodohippuric Acid; Kidney Diseases; M | 1982 |
Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chlorothiazide; Dipeptides; Diuretics; E | 1984 |
Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Female; Furosemide; Humans; Hypertension; Kidney Diseases; | 1984 |
Renal insufficiency with combinations of angiotensin converting enzyme inhibitors and diuretics.
Topics: Furosemide; Humans; Hypertension; Kidney Diseases | 1984 |
Intraoperative urinary output does not predict postoperative renal function in patients undergoing abdominal aortic revascularization.
Topics: Anuria; Aorta, Abdominal; Blood Urea Nitrogen; Constriction; Creatinine; Furosemide; Humans; Intraop | 1984 |
Response of peripheral plasma renin activity (PRA) to furosemide stimulation; reduction of the renal parenchyma as a limiting factor.
Topics: Adult; Female; Furosemide; Humans; Hypertension; Hypertension, Renovascular; Kidney Diseases; Kidney | 1981 |
[Comparative nephrotoxicity of latamoxef and other cephalosporins in rabbits. Combined administration with furosemide or tobramycin. (author's transl)].
Topics: Animals; Anti-Bacterial Agents; Blood Chemical Analysis; Cephalosporins; Cephamycins; Drug Synergism | 1981 |
Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function.
Topics: Creatinine; Diuresis; Electrolytes; Furosemide; Humans; Kidney Diseases; Kidney Failure, Chronic; Ki | 1984 |
[Early detection and differential diagnosis of renal insufficiency following cardiac surgery--diagnostic value of free water clearance and fractional excretion of sodium].
Topics: Adolescent; Adult; Body Water; Cardiac Surgical Procedures; Child; Child, Preschool; Creatinine; Dia | 1984 |
[Pharmacokinetics of furosemide in infants with pneumonia and/or other diseases].
Topics: Bronchitis; Female; Furosemide; Humans; Infant; Infant, Newborn; Kidney Diseases; Kinetics; Male; Pn | 1983 |
Quantitative determination of furosemide in plasma, plasma water, urine and ascites fluid by high-performance liquid chromatography.
Topics: Ascitic Fluid; Blood Proteins; Chromatography, High Pressure Liquid; Furosemide; Humans; Kidney Dise | 1984 |
Renal function during cefuroxime treatment in patients with pre-existing renal impairment.
Topics: Cefuroxime; Cephaloridine; Cephalosporins; Edetic Acid; Furosemide; Gentamicins; Glomerular Filtrati | 1980 |
Effects of furosemide and orthostasis on active and inactive renin in normal and anephric man.
Topics: Adult; Angiotensin II; Child; Female; Furosemide; Humans; Kidney Diseases; Male; Nephrectomy; Postur | 1981 |
[Pharmacologic urography in the diagnosis of disorders of the upper urinary tract].
Topics: Adolescent; Adult; Child, Preschool; Female; Furosemide; Humans; Kidney Diseases; Kidney Function Te | 1983 |
Pharmacokinetics and clinical effects of cefuroxime in patients with severe renal insufficiency.
Topics: Aged; Cefuroxime; Cephalosporins; Creatinine; Female; Furosemide; Humans; Kidney Diseases; Kinetics; | 1983 |
[Hypomagnesemic coma during therapy of septicaemia in a patient with acute lymphoblastic leukemia. (author's transl)].
Topics: Child; Coma; Furosemide; Gentamicins; Humans; Kidney Diseases; Leukemia, Lymphoid; Magnesium; Magnes | 1981 |
The relative roles of sodium and renin in the hypertension of renal disease. An assessment based on the response to frusemide and propranolol.
Topics: Adolescent; Adult; Aged; Creatinine; Female; Furosemide; Humans; Hypertension, Renal; Kidney Disease | 1981 |
[Therapy of cardiac insufficiency with diuretics].
Topics: Amiloride; Benzothiadiazines; Blood Glucose; Diuretics; Drug Administration Schedule; Female; Furose | 1982 |
Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms.
Topics: Adolescent; Adult; Aged; Blood Platelet Disorders; Cisplatin; Doxorubicin; Drug Administration Sched | 1980 |
[Studies on the nephrotoxicity of cephaloridine in the mouse (author's transl)].
Topics: Animals; Cephaloridine; Drinking; Female; Furosemide; Kidney Diseases; Mice | 1982 |
Hearing loss in end-stage renal disease - effect of dialysis.
Topics: Furosemide; Gentamicins; Hearing Disorders; Humans; Kanamycin; Kidney Diseases; Male; Renal Dialysis | 1980 |
Gentamicin-induced nephrotoxicity in mice: protection by loop diuretics.
Topics: Acetylglucosaminidase; Bumetanide; Diuretics; Furosemide; Gentamicins; Kidney; Kidney Diseases; Kidn | 1981 |
The dilated non-obstructed renal pelvis.
Topics: Adolescent; Adult; Dilatation, Pathologic; Female; Follow-Up Studies; Furosemide; Humans; Kidney Dis | 1981 |
Frusemide enhancement of netilmicin nephrotoxicity in dogs.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Dogs; Furosemide; Gentamicins; Glucuronidase; Hexosaminida | 1981 |
Renal functions and clinical disorders in the neonate.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Asphyxia Neonatorum; Furosemide; Humans; Indomethacin; I | 1981 |
Treatment of hepatorenal syndrome.
Topics: Adult; Ascites; Ascitic Fluid; Creatine; Furosemide; Humans; Infusions, Parenteral; Kidney Diseases; | 1980 |
The influence of sodium status and furosemide on canine acute amphotericin B nephrotoxicity.
Topics: Amphotericin B; Animals; Dogs; Female; Furosemide; Glomerular Filtration Rate; Kidney; Kidney Diseas | 1980 |
Furosemide in patients with heart failure: shift in dose-response curves.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Humans; Kidney Dis | 1980 |
Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril.
Topics: Animals; Biphenyl Compounds; Blood Pressure; Cyclosporine; Enalapril; Furosemide; Hydralazine; Imida | 1995 |
[Intervention in nuclear medicine kidney diagnosis].
Topics: Aged; Angiography, Digital Subtraction; Captopril; Female; Furosemide; Humans; Hydronephrosis; Infan | 1995 |
[The protective effects of two hydration protocols against cisplatin nephrotoxicity].
Topics: Adult; Breast Neoplasms; Cisplatin; Female; Furosemide; Humans; Kidney; Kidney Diseases; Male; Middl | 1994 |
[Therapeutic bilateral renal artery embolization in the nephrotic syndrome].
Topics: Amyloidosis; Captopril; Cardiomyopathies; Contraindications; Creatinine; Crohn Disease; Drug Therapy | 1994 |
A method to evaluate renal ammoniagenesis in vivo.
Topics: Adult; Ammonia; Ammonium Chloride; Animals; Diuresis; Dogs; Female; Furosemide; Humans; Hydrogen-Ion | 1993 |
Renal hypouricemia with both drug-insensitive secretion and defective reabsorption of urate: a novel type of renal hypouricemia.
Topics: Adult; Creatinine; Drug Resistance; Extracellular Space; Furosemide; Humans; Inosine; Kidney Disease | 1993 |
Transport defects of rabbit medullary thick ascending limb cells in obstructive nephropathy.
Topics: Animals; Biological Transport, Active; Bumetanide; Carrier Proteins; Cell Membrane; Furosemide; Kidn | 1993 |
Guanidinoacetic acid (GAA) synthesis in rat tubular suspension as a system for evaluating gentamicin (GM) nephrotoxicity.
Topics: Animals; Anti-Bacterial Agents; Diuretics; Dose-Response Relationship, Drug; Furosemide; Gentamicins | 1995 |
Biochemical interaction between Tamm-Horsfall glycoprotein and Ig light chains in the pathogenesis of cast nephropathy.
Topics: Colchicine; Furosemide; Humans; Hydrogen-Ion Concentration; Immunoglobulin Light Chains; Kidney Dise | 1995 |
Multiple tubular dysfunction induced by mixed Chinese herbal medicines containing cadmium.
Topics: Adult; Cadmium; Drugs, Chinese Herbal; Female; Furosemide; Humans; Hydrochlorothiazide; Kidney Disea | 1996 |
Renal imaging with 99Tc(m)-dextran.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Dextrans; Female; Furosemide; Humans; Injections, | 1997 |
Value of diuresis renography in the post-natal period of assumed physiological renal immaturity.
Topics: Child; Child, Preschool; Diuresis; Female; Furosemide; Humans; Infant; Infant, Newborn; Kidney; Kidn | 1997 |
Contrast-associated nephropathy--old clinical problem and new therapeutic perspectives.
Topics: Contrast Media; Creatinine; Diuretics; Female; Furosemide; Humans; Incidence; Kidney Cortex; Kidney | 1998 |
Dismembered pyeloplasty followed by metachronous ureteropelvic junction obstruction in the contralateral kidney.
Topics: Diuretics; Furosemide; Humans; Hydronephrosis; Infant, Newborn; Kidney Diseases; Kidney Pelvis; Post | 2000 |
Tc-99m MAG3 scintigraphy in unusually dilated bilateral extrarenal pelves.
Topics: Aged; Dilatation, Pathologic; Diuretics; Furosemide; Humans; Kidney Calices; Kidney Diseases; Kidney | 2000 |
Metabonomics: evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants.
Topics: 1-Naphthylisothiocyanate; Aminophenols; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liv | 2000 |
Co-administration of furosemide augments tacrolimus-induced impairment in kidney function in rats.
Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Diuretics; Drug Synergism; Furosemide; Ki | 2000 |
MAG3-F0 scintigraphy in decision making for emergency intervention in renal colic after helical CT positive for a urolith.
Topics: Adult; Aged; Colic; Diuretics; Emergencies; Female; Furosemide; Humans; Kidney Diseases; Male; Middl | 2000 |
The diuretic- and Bartter-like salt-losing tubulopathies.
Topics: Anion Transport Proteins; Bartter Syndrome; Benzothiadiazines; Chloride Channels; Diuretics; Furosem | 2000 |
Renal cortical scintigraphy and diuresis renography in infants and children.
Topics: Child, Preschool; Consensus Development Conferences as Topic; Diuretics; Female; Furosemide; Humans; | 2001 |
The choice of timing for diuresis renography: the F + 0 method.
Topics: Adult; Aged; Aged, 80 and over; Dilatation, Pathologic; Diuretics; Female; Furosemide; Humans; Injec | 2001 |
A comparison of unenhanced helical computerized tomography findings and renal obstruction determined by furosemide 99m technetium mercaptoacetyltriglycine diuretic scintirenography for patients with acute renal colic.
Topics: Acute Disease; Adolescent; Adult; Aged; Colic; Diuretics; Female; Furosemide; Humans; Kidney Disease | 2002 |
[Functional furosemide loading test. Practical use in children with kidney diseases].
Topics: Adolescent; Child; Child, Preschool; Diuresis; Diuretics; Furosemide; Humans; Hydrogen-Ion Concentra | 2001 |
Diuretic-induced renal impairment without volume depletion in cirrhosis: changes in the renin-angiotensin system and the effect of beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Adult; Creatinine; Female; Furosemide; Humans; Kidney; Kidney Diseases; | 1979 |
Effect of furosemide on the urinary excretion of some plasma proteins.
Topics: Adolescent; Adult; alpha-Macroglobulins; Blood Proteins; Capillary Permeability; Female; Furosemide; | 1978 |
Renal involvement in progressive systemic sclerosis: prolonged survival with aggressive antihypertensive management.
Topics: Adult; Antihypertensive Agents; Cardiomegaly; Digoxin; Drug Therapy, Combination; Female; Furosemide | 1979 |
Treatment of complicated hypertension.
Topics: Acute Disease; Cerebral Hemorrhage; Cerebrovascular Disorders; Chronic Disease; Coronary Disease; Di | 1977 |
Pharmacokinetics/pharmacodynamics of furosemide in man: a review.
Topics: Biological Availability; Dose-Response Relationship, Drug; Drug Interactions; Furosemide; Heart Fail | 1979 |
Furosemide-induced ototoxicity.
Topics: Adolescent; Adult; Aged; Aminoglycosides; Ethacrynic Acid; Female; Furosemide; Hearing Loss; Humans; | 1979 |
[Clinical evaluation of the mechanisms of the action of Lasix in diffuse kidney lesions].
Topics: Adult; Biological Transport, Active; Drug Evaluation; Furosemide; Humans; Kidney Diseases; Kidney Tu | 1979 |
[Furosemide-induced nephropathy (author's transl)].
Topics: Aged; Female; Furosemide; Humans; Kidney; Kidney Diseases; Self Medication | 1979 |
Renal and hepatic necrosis after metabolic activation of 2-substituted furans and thiophenes, including furosemide and cephaloridine.
Topics: Animals; Cephaloridine; Chemical and Drug Induced Liver Injury; Furans; Furosemide; In Vitro Techniq | 1977 |
[Renal toxicity of the association: gentamicin/furosemide. One case (author's transl)].
Topics: Adult; Drug Therapy, Combination; Furosemide; Gentamicins; Hepatitis B; Humans; Kidney Diseases; Liv | 1978 |
[Radioisotope renography with "lasix load"].
Topics: Adolescent; Adult; Female; Furosemide; Humans; Iodine Radioisotopes; Iodohippuric Acid; Kidney Disea | 1978 |
Furosemide-induced adverse reactions during hospitalization.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Child; Chile; Dose-Response Relationship, Drug; Dr | 1978 |
The use of furosemide in the treatment of edema in infants and children.
Topics: Administration, Oral; Adolescent; Body Weight; Edema; Furosemide; Heart Diseases; Humans; Infusions, | 1978 |
[Acoustic-vestibular symptoms in chronic renal insufficiency].
Topics: Adult; Aminoglycosides; Chronic Disease; Drug Interactions; Female; Furosemide; Hearing Disorders; H | 1976 |
Molecular basis for several drug-induced nephropathies.
Topics: Acetaminophen; Analgesics; Animals; Carbon Tetrachloride Poisoning; Cephaloridine; Chloroform; Cytoc | 1977 |
[Case of hypokalemic nephropathy].
Topics: Adult; Diuretics; Female; Furosemide; Humans; Hypokalemia; Kidney Diseases; Pyelonephritis; Substanc | 1977 |
Progress in hepatology. Metabolic activation of drugs to toxic substances.
Topics: Acetaminophen; Animals; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Chemical Pheno | 1975 |
Clinical types and drug therapy of renal impairment in cirrhosis.
Topics: Acute Kidney Injury; Diagnosis, Differential; Diuretics; Furosemide; Humans; Kidney Diseases; Liver | 1975 |
[A question of logic].
Topics: Diazoxide; Furosemide; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases; Male; Middle Aged; | 1976 |
Contrast-induced nephrotoxicity: the effects of vasodilator therapy.
Topics: Aged; Angiography; Calcium Channel Blockers; Contrast Media; Creatinine; Diabetes Mellitus, Type 1; | 1992 |
Renal response to atrial natriuretic peptide in nonedematous sodium-retaining dogs.
Topics: Animals; Atrial Natriuretic Factor; Dogs; Edema; Female; Fludrocortisone; Furosemide; Glomerular Fil | 1992 |
Kidney function in very low birth weight infants with furosemide-related renal calcifications at ages 1 to 2 years.
Topics: Absorption; Calcinosis; Calcium; Carbon Dioxide; Creatinine; Female; Furosemide; Humans; Infant; Inf | 1992 |
Geriatrics nephrology.
Topics: Aged; Aging; Captopril; Digoxin; Furosemide; Heart Failure; Humans; Hypertension; Kidney Diseases; L | 1992 |
Why renography can fail in the diagnosis of upper urinary tract obstruction.
Topics: Adult; Female; Furosemide; Humans; Kidney Diseases | 1992 |
Pathobiology of cast nephropathy from human Bence Jones proteins.
Topics: Animals; Bence Jones Protein; Carbohydrates; Colchicine; Furosemide; Humans; Kidney Diseases; Male; | 1992 |
Hyperechoic renal medullary pyramids in infants and children.
Topics: Acidosis, Renal Tubular; Acute Kidney Injury; Adolescent; Bartter Syndrome; Calcium; Child; Child, P | 1991 |
Hyperechoic renal medullary pyramids in infants and children.
Topics: Child; Furosemide; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Kidney Diseases; Ki | 1991 |
[Dynamic scintigraphy of the kidneys using lasix].
Topics: Adolescent; Adult; Aged; Female; Furosemide; Humans; Hydronephrosis; Kidney; Kidney Calculi; Kidney | 1991 |
[Does furosemide prevent changes in renal function induced by administration of indomethacin in premature infants?].
Topics: Furosemide; Humans; Indomethacin; Infant, Newborn; Infant, Premature; Kidney Diseases | 1990 |
Renal tubular hypouricemia: evidence for defect of both secretion and reabsorption.
Topics: Aged; Aspirin; Creatinine; Furosemide; Humans; Kidney Diseases; Kidney Function Tests; Kidney Tubule | 1990 |
Successful medical management of presumed spontaneous decapsulation of a transplant kidney.
Topics: Adult; Amiloride; Female; Furosemide; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Posto | 1990 |
[Antitumor effectiveness and nephrotoxicity of oxoplatinum].
Topics: Acetazolamide; Animals; Antineoplastic Agents; Carcinoma, Krebs 2; Cisplatin; Drug Therapy, Combinat | 1990 |
Spontaneous urinary extravasation during a diuretic radionuclide renal study. Report of two cases.
Topics: Aged; Aged, 80 and over; Extravasation of Diagnostic and Therapeutic Materials; Female; Furosemide; | 1990 |
Renal scintigraphy in the diagnosis and surgical management of a patient with caliceal colic: a case report.
Topics: Adult; Colic; Female; Furosemide; Humans; Kidney Calculi; Kidney Calices; Kidney Diseases; Radioisot | 1990 |
Acute and steady-state pharmacokinetics and antihypertensive effects of felodipine in patients with normal and impaired renal function.
Topics: Adult; Aged; Biological Availability; Blood Pressure; Felodipine; Female; Furosemide; Glomerular Fil | 1990 |
Toxicology and carcinogenicity studies of diuretics in F344 rats and B6C3F1 mice. 2. Furosemide.
Topics: Adenoma; Animals; Body Weight; Brain Neoplasms; Carcinogens; Diuretics; Female; Furosemide; Hyperpla | 1990 |
[Plasma angiotensin II assay and the clinical significance].
Topics: Angiotensin II; Chromatography, High Pressure Liquid; Diet, Sodium-Restricted; Furosemide; Humans; H | 1990 |
[The 25th birthday of Lasilix: contributions of furosemide to renal physiology and therapy].
Topics: Diuretics; Furosemide; Heart Failure; Humans; Hypertension; Kidney Diseases | 1990 |
Metabolism of the diuretic bumetanide in healthy subjects and patients with renal impairment.
Topics: Aged; Bumetanide; Diuretics; Female; Furosemide; Half-Life; Humans; Kidney Diseases; Male; Middle Ag | 1990 |
Lisinopril in hypertension associated with renal impairment.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalapril; Female; Furosemide | 1987 |
Cisplatin: nephrotoxic action in vertebrates and its prevention.
Topics: Animals; Choline; Cisplatin; Columbidae; Ethacrynic Acid; Female; Fishes; Furosemide; Kidney Disease | 1989 |
Interaction of furosemide with serum thyroxine-binding sites: in vivo and in vitro studies and comparison with other inhibitors.
Topics: Binding, Competitive; Charcoal; Dextrans; Dialysis; Furosemide; Humans; In Vitro Techniques; Kidney | 1985 |
[Idiopathic and diuretic-induced edema].
Topics: Adult; Dose-Response Relationship, Drug; Edema; Female; Furosemide; Humans; Kidney Diseases; Kidney | 1989 |
Potential protective effects of furosemide against early renal injury in liver transplant patients receiving cyclosporine-A.
Topics: Cyclosporins; Furosemide; Humans; Kidney Diseases; Liver Transplantation; Postoperative Complication | 1989 |
Potential protective effects of furosemide against early cyclosporine-induced renal injury in hepatic transplant recipients.
Topics: Cyclosporins; Furosemide; Humans; Kidney; Kidney Diseases; Liver Transplantation | 1989 |
Lisinopril in the treatment of hypertensive patients with renal impairment.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Enalapril; Female; | 1988 |
Studies of renin activation and regulation of aldosterone and 18-hydroxycorticosterone biosynthesis in hyporeninemic hypoaldosteronism.
Topics: 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Corticosterone; Enz | 1985 |
Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction.
Topics: Adult; Aged; Blood Pressure; Drug Therapy, Combination; Enalapril; Female; Furosemide; Heart Rate; H | 1986 |
The pharmacokinetics of ceftazidime in patients with impaired renal function and concurrent frusemide therapy.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Ceftazidime; Creatinine; Female; Furosemide; G | 1988 |
Ultrasound diagnosis of renal calcification in infants on chronic furosemide therapy.
Topics: Bone and Bones; Bone Diseases; Calcinosis; Chronic Disease; Furosemide; Humans; Infant; Infant, Low | 1986 |
Clinical evaluation of segmental tubular reabsorption of sodium and fluid in man: lithium vs free water clearances.
Topics: Furosemide; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney Tubules; Lithium; Sodium; Ur | 1987 |
[Administration of high doses of cisplatin in 20-minute infusions].
Topics: Cisplatin; Fluid Therapy; Furosemide; Humans; Infusions, Intravenous; Kidney Diseases; Mannitol; Neo | 1988 |
[Determination of furosemide and its metabolic products in plasma and urine by high performance liquid chromatography and clinical application].
Topics: Adolescent; Adult; Chromatography, High Pressure Liquid; Female; Furosemide; Humans; Kidney Diseases | 1988 |
Renal calcification incidence in very low birth weight infants.
Topics: Calcinosis; Calcium; Creatinine; Furosemide; Humans; Infant, Low Birth Weight; Infant, Newborn; Infa | 1988 |
Renin-aldosterone system and renal function under cyclosporine A.
Topics: Aldosterone; Creatinine; Cyclosporins; Diabetes Mellitus, Type 1; Furosemide; Glomerular Filtration | 1988 |
Pharmacologic probing of mercuric chloride-induced renal dysfunction in the neonatal rat.
Topics: Acetazolamide; Amiloride; Animals; Animals, Newborn; Chlorothiazide; Diuretics; Furosemide; Kidney; | 1987 |
[Pharmacourography using furosemide].
Topics: Furosemide; Humans; Kidney Diseases; Urography | 1987 |
[Indomethacin and furosemide in closure of ductus arteriosus].
Topics: Drug Evaluation; Ductus Arteriosus, Patent; Female; Furosemide; Humans; Indomethacin; Infant, Newbor | 1986 |
Frusemide intravenous urography in the diagnosis of pelviureteric junction obstruction.
Topics: Constriction, Pathologic; Contrast Media; Furosemide; Humans; Kidney Diseases; Kidney Pelvis; Method | 1985 |
Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide.
Topics: Acetazolamide; Animals; Body Weight; Cisplatin; Creatinine; Diet; Furosemide; Glomerular Filtration | 1985 |
[Indications for therapy with diuretics].
Topics: Aldosterone; Blood Volume; Cardiac Output; Diuretics; Edema; Edema, Cardiac; Furosemide; Humans; Kid | 1985 |
Bilateral loin pain after oral frusemide.
Topics: Dilatation; Furosemide; Heart Failure; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Pain | 1973 |
Frusemide as inhibitor of prolactin action.
Topics: Animals; Breast Neoplasms; Drug Interactions; Female; Furosemide; Kidney Diseases; Lactation; Male; | 1973 |
Frusemide renography.
Topics: Aged; Furosemide; Humans; Kidney Diseases; Male; Middle Aged; Radioisotope Renography | 1967 |
Localization of urinary-tract infection.
Topics: Bacteriuria; Diagnosis, Differential; Furosemide; Humans; Kidney Diseases; Urinary Bladder Diseases; | 1969 |
Arterial hypertension--northwest Florida public health survey. II. Diagnosis and treatment.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Chlorothiazide; Diuretics | 1974 |
Suppressed renin response in unilaterally nephrectomized subjects.
Topics: Adult; Angiotensin II; Creatinine; Female; Furosemide; Humans; Hypertension, Renal; Kidney; Kidney D | 1972 |
Angiotensin II plasma levels in hypertensive patients.
Topics: Adenoma; Adrenal Gland Neoplasms; Angiotensin II; Female; Furosemide; Humans; Hyperaldosteronism; Hy | 1972 |
Diuretic properties of furosemide in renal disease.
Topics: Acid-Base Equilibrium; Adolescent; Adult; Aged; Amyloidosis; Blood Urea Nitrogen; Creatine; Diabetic | 1968 |
[Importance of cast excretion following administration of diuretics].
Topics: Ethacrynic Acid; Fluorescent Antibody Technique; Furosemide; Humans; Hydrogen-Ion Concentration; Kid | 1972 |
Peripheral and renal venous plasma renin concentration in hypertensive patients with unilateral renal or renovascular disease.
Topics: Adult; Brachial Artery; Catheterization; Female; Furosemide; Glomerular Filtration Rate; Humans; Kid | 1972 |
Self-induced secondary hyperaldosteronism simulating Bartter's syndrome.
Topics: Adult; Alkalosis; Diagnosis, Differential; Female; Furosemide; Humans; Hyperaldosteronism; Hypertrop | 1972 |
[Therapy of severe purulent menigitides].
Topics: Ampicillin; Chlormethiazole; Diazepam; Furosemide; Gentamicins; Humans; Injections, Intravenous; Kid | 1973 |
Use of a new diuretic agent (metolazone) in patients with edema and ascites.
Topics: Ascites; Blood Urea Nitrogen; Creatinine; Diuretics; Edema; Furosemide; Humans; Injections, Intraven | 1973 |
[Diuretics in acute glomerulonephritis?].
Topics: Acute Disease; Diuretics; Ethacrynic Acid; Furosemide; Glomerulonephritis; Humans; Kidney Diseases; | 1973 |
The effects of maleic acid and uranyl on mercurial diuresis in dogs.
Topics: Acetates; Acetazolamide; Animals; Chlorides; Diuresis; Dogs; Ethacrynic Acid; Furosemide; Hydrochlor | 1973 |
Letter: Hepatorenal syndrome and prolactin.
Topics: Animals; Furosemide; Humans; Kidney Diseases; Liver Diseases; Prolactin; Rats; Syndrome | 1974 |
Treatment of malignant hypertension. The influence of etiology on the survival in 12 consecutive patients.
Topics: Adult; Antihypertensive Agents; Diet, Sodium-Restricted; Dipyridamole; Female; Furosemide; Heparin; | 1974 |
Letter: Metindamide as a diuretic.
Topics: Benzamides; Diuretics; Edema; Furosemide; Humans; Indoles; Kidney Diseases | 1974 |
Oral diuretics and renal pain--a provocative test.
Topics: Adult; False Negative Reactions; Furosemide; Humans; Hydronephrosis; Kidney Diseases; Kidney Tubules | 1972 |
Pharmacokinetics of procainamide.
Topics: Acetazolamide; Animals; Bile; Blood Urea Nitrogen; Creatinine; Dogs; Furosemide; Humans; Hydrogen-Io | 1972 |
[Furosemide-induced deafness in decreased kidney function].
Topics: Administration, Oral; Deafness; Furosemide; Humans; Infusions, Parenteral; Kidney Diseases | 1972 |
[Clinico-pharmacological studies of furosemide].
Topics: Furosemide; Glomerular Filtration Rate; Heart Diseases; Humans; Kidney Diseases; Liver Diseases; Nat | 1971 |
Clinical use of furosemide.
Topics: Blood Pressure; Blood Urea Nitrogen; Chlorothiazide; Diuresis; Furosemide; Glomerular Filtration Rat | 1966 |
Renal vasodilator therapy in the hepatorenal syndrome.
Topics: Furosemide; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Vasodilator Agents | 1970 |
[Triamterene-frusemide combination in edematous patients].
Topics: Adult; Ascites; Body Weight; Diuresis; Diuretics; Drug Synergism; Edema; Electrolytes; Female; Furos | 1970 |
Diuretics in renal disease.
Topics: Adult; Diuresis; Diuretics; Ethacrynic Acid; Female; Furosemide; Humans; Kidney Diseases; Kidney Fai | 1969 |
Adjuncts to renal preservation.
Topics: Animals; Creatinine; Cyanides; Ethacrynic Acid; Furosemide; Glucose; Hexoses; Hydrocortisone; Insuli | 1969 |
Lead intoxication: its effect on the renin-aldosterone response to sodium deprivation.
Topics: Alcohol Drinking; Aldosterone; Furosemide; Humans; Kidney Diseases; Lead Poisoning; Male; Renin; Sod | 1970 |
Ototoxicity induced by furosemide.
Topics: Adult; Deafness; Ear Diseases; Female; Furosemide; Humans; Injections, Intravenous; Kidney Diseases; | 1970 |
[Use of lasix (furosemide) in renal edema].
Topics: Edema; Furosemide; Humans; Kidney Diseases | 1970 |
[Therapy with diuretics in renal insufficiency. Trials made with furosemide].
Topics: Diuresis; Electrolytes; Female; Furosemide; Glomerular Filtration Rate; Humans; Kidney Diseases; Kid | 1970 |
The nephrotoxicity of cephaloridine.
Topics: Animals; Cephaloridine; Drug Synergism; Furosemide; Kidney Diseases; Rabbits; Rats; Renin | 1970 |
Clinical usage of the newer diuretic agents.
Topics: Diuretics; Ethacrynic Acid; Furosemide; Humans; Hypokalemia; Kidney Diseases; Spironolactone; Triamt | 1970 |
[Comparative evaluation of intravenous diuretics: Furosemide (Polfa), Lasix (Hoechst), Edecrin Lyovac (Merck, Sharp and Dohme). II. Studies in renal diseases].
Topics: Adolescent; Adult; Aged; Ethacrynic Acid; Female; Furosemide; Humans; Injections, Intravenous; Kidne | 1970 |
[Treatment of the so-called hepatorenal syndrome].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Diet, Sodium-Restricted; Dietary Carbohydrates; Dietary | 1968 |
Diuretic response of a severely diseased kidney to furosemide.
Topics: Adult; Aged; Chlorothiazide; Diet, Sodium-Restricted; Diuresis; Drug Synergism; Female; Furosemide; | 1968 |
[A clinical study with 4-chloro-N-(furylmethyl) 5-sulfamoyl-anthranilic acid (Lasix)].
Topics: Diabetes Insipidus; Diuresis; Furosemide; Glomerular Filtration Rate; Humans; Injections, Intravenou | 1968 |
[Study of the diuretic effect of furosemide].
Topics: Adult; Diuresis; Female; Furosemide; Humans; Kidney Diseases; Male; Middle Aged | 1968 |
Use of hypertonic saline, clopamide and furosemide for evaluation of the concentrating defect in pitressin-treated diabetes insipidus.
Topics: Amides; Clopamide; Diabetes Insipidus; Diuretics; Female; Furosemide; Humans; Hypertonic Solutions; | 1968 |
The correlation of fractional excretion of sodium and magnesium in the chronically diseased kidney of dog and man.
Topics: Animals; Blood Urea Nitrogen; Chronic Disease; Dogs; Female; Furosemide; Glomerular Filtration Rate; | 1969 |
[On the use of furosemide in restricted kidney function].
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Diuretics; Female; Furosemide; Humans; Kidney Diseases | 1965 |
[Action of furosemid on renal hemodynamics. I. Response to its intravenous injection in normal subjects and patients with renal function disorders].
Topics: Diuresis; Diuretics; Furosemide; Humans; Hypertension; Kidney Diseases | 1966 |
Diuretic drugs in patients with impaired renal function.
Topics: Diuretics; Ethacrynic Acid; Furosemide; Glomerular Filtration Rate; Humans; Kidney Diseases; Kidney | 1966 |
Diuretic response to furosemide in the presence of renal insufficiency.
Topics: Adult; Aged; Diuretics; Edema; Female; Furosemide; Humans; Kidney Diseases; Male; Middle Aged | 1966 |
Stop-flow analysis in man.
Topics: Aminohippuric Acids; Chlorides; Female; Furosemide; Humans; Inulin; Kidney Diseases; Kidney Function | 1966 |
[Clinico-pharmacological studies on the effect of furosemide on the free water clearance].
Topics: Chlorides; Diuresis; Furosemide; Humans; Inulin; Kidney Diseases; Osmosis; Photometry; Potassium; Po | 1966 |
[Experience with a new diuretic Furosemide].
Topics: Edema; Furosemide; Heart Failure; Humans; Kidney Diseases; Liver Diseases | 1966 |